CHMP2B (Charged multivesicular body protein 2b) is a core component of the ESCRT-III (Endosomal Sorting Complex Required for Transport III) machinery, belonging to the evolutionarily conserved SNF7 family. CHMP2B functions as a structural subunit that assembles into helical polymers on membranes to mediate reverse-topology membrane scission events. The protein participates in multiple cellular processes including multivesicular body (MVB) formation and cargo sorting, cytokinetic abscission at the midbody, nuclear envelope reformation during telophase, plasma membrane repair, autophagosome maturation, and viral budding (particularly HIV-1). CHMP2B is recruited to membrane necks where it cooperates with other ESCRT-III subunits (CHMP4B, CHMP3) and the AAA ATPase VPS4 for membrane remodeling and fission. Mutations in CHMP2B cause frontotemporal dementia and/or amyotrophic lateral sclerosis (FTDALS7), demonstrating the critical importance of ESCRT-III function in neuronal homeostasis. The protein contains an N-terminal MIT-interacting motif that mediates interaction with VPS4, and post-translational modifications including K6 methylation by SMYD2 regulate its polymerization dynamics and abscission timing.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005771
multivesicular body
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: CHMP2B is a core ESCRT-III subunit with well-established localization to multivesicular bodies. This is supported by phylogenetic conservation across eukaryotes and extensive experimental evidence showing CHMP2B at MVB membranes (PMID:16554368, PMID:16041373).
Reason: Core localization for ESCRT-III function. CHMP2B localizes to MVB membranes where it participates in intraluminal vesicle formation. The IBA annotation is well-supported by the phylogenetic analysis and corroborated by multiple IDA annotations.
Supporting Evidence:
file:human/CHMP2B/CHMP2B-deep-research-falcon.md
model: Edison Scientific Literature
|
|
GO:0015031
protein transport
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: CHMP2B participates in protein transport through its role in the MVB pathway, which sorts ubiquitinated membrane proteins for lysosomal degradation.
Reason: The MVB pathway is fundamentally a protein transport pathway, sorting ubiquitinated cargo into intraluminal vesicles for subsequent lysosomal degradation. This is a core function of ESCRT-III components including CHMP2B.
|
|
GO:0032509
endosome transport via multivesicular body sorting pathway
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: CHMP2B is essential for the MVB sorting pathway, mediating endosomal cargo transport through its role in intraluminal vesicle formation.
Reason: This is a core function of CHMP2B as an ESCRT-III subunit. The protein is required for the proper formation of intraluminal vesicles within MVBs, enabling cargo sorting and transport.
|
|
GO:0045324
late endosome to vacuole transport
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: CHMP2B participates in transport from late endosomes to lysosomes (the mammalian equivalent of vacuoles) through its role in MVB biogenesis and fusion.
Reason: This represents the conserved ESCRT-III function in endolysosomal transport. The term is appropriate for the mammalian system where lysosomes serve the function of yeast vacuoles.
|
|
GO:0000815
ESCRT III complex
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: CHMP2B is a bona fide subunit of the ESCRT-III complex, confirmed by both phylogenetic analysis and direct biochemical evidence.
Reason: CHMP2B is a core ESCRT-III subunit belonging to the SNF7 family. Its membership in the complex is unequivocally established through structural, biochemical, and functional studies.
|
|
GO:0000776
kinetochore
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: ESCRT-III components including CHMP2B have been shown to localize to kinetochores during mitosis, supported by IDA evidence from PMID:26040712.
Reason: This IEA annotation is corroborated by direct experimental evidence (IDA from PMID:26040712). CHMP2B localizes to kinetochores as part of its mitotic functions in spindle maintenance and chromosome segregation.
|
|
GO:0001778
plasma membrane repair
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: ESCRT-III machinery is required for plasma membrane repair, supported by IDA evidence from PMID:24482116.
Reason: This IEA annotation is validated by direct experimental evidence. The ESCRT machinery performs membrane sealing functions during plasma membrane repair, analogous to its role in other membrane fission events.
|
|
GO:0005643
nuclear pore
|
IEA
GO_REF:0000117 |
KEEP AS NON CORE |
Summary: CHMP2B has been detected at nuclear pores as part of ESCRT-III function in nuclear envelope reformation, though its primary localization is at sites of annular fusion rather than mature nuclear pores.
Reason: CHMP2B localizes to nucleo-cytoplasmic channels during nuclear envelope reformation (PMID:26040713), which are precursors to nuclear pore formation. However, it is not a stable component of mature nuclear pore complexes. This is a transient localization related to its membrane sealing function.
|
|
GO:0005765
lysosomal membrane
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: CHMP2B localizes to lysosomal membranes as part of the endolysosomal pathway, supported by IDA evidence from PMID:17984323.
Reason: The annotation is supported by direct experimental evidence showing CHMP2B localization to lysosomal membranes in the context of autophagy and MVB-lysosome fusion.
|
|
GO:0005828
kinetochore microtubule
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: ESCRT-III components localize to kinetochore microtubules during mitosis, supported by IDA evidence from PMID:26040712.
Reason: This annotation is validated by direct experimental evidence showing ESCRT-III localization at spindle poles and kinetochore microtubules.
|
|
GO:0005829
cytosol
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: CHMP2B is present in the cytosol in its soluble, inactive form before recruitment to membranes.
Reason: ESCRT-III proteins exist in an autoinhibited soluble form in the cytosol and are recruited to membranes upon activation. This is well-established for CHMP2B.
|
|
GO:0007034
vacuolar transport
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: InterPro-based annotation reflecting CHMP2B's role in vacuolar/lysosomal transport as an ESCRT-III subunit.
Reason: The SNF7 domain annotation appropriately maps to vacuolar transport function. In mammalian cells, this corresponds to lysosomal transport pathways.
|
|
GO:0007080
mitotic metaphase chromosome alignment
|
IEA
GO_REF:0000117 |
KEEP AS NON CORE |
Summary: ESCRT-III depletion affects chromosome alignment during mitosis, supported by IMP evidence from PMID:20616062.
Reason: While CHMP2B depletion does affect chromosome alignment (PMID:20616062), this represents a secondary consequence of centrosome/spindle defects rather than a direct function. The core ESCRT-III function is membrane remodeling.
|
|
GO:0015031
protein transport
|
IEA
GO_REF:0000043 |
ACCEPT |
Summary: UniProt keyword-based annotation for protein transport, reflecting CHMP2B's role in sorting and trafficking.
Reason: Appropriately broad annotation that captures CHMP2B's role in protein sorting through the MVB pathway. Duplicates the IBA annotation but from a different source.
|
|
GO:0030496
midbody
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: CHMP2B localizes to the midbody during cytokinesis, supported by IDA evidence from PMID:26040712.
Reason: Midbody localization is a core feature of ESCRT-III function in cytokinetic abscission. Well-validated by direct experimental evidence.
|
|
GO:0031468
nuclear membrane reassembly
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: CHMP2B participates in nuclear envelope reformation during telophase, supported by IMP evidence from PMID:26040713.
Reason: This is a validated core function of ESCRT-III. The complex is recruited to sites of annular fusion during nuclear envelope reformation.
|
|
GO:0031902
late endosome membrane
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: CHMP2B localizes to late endosome membranes as part of the MVB pathway.
Reason: Core localization for ESCRT-III function in MVB biogenesis. Late endosomes are the site of intraluminal vesicle formation.
|
|
GO:0032585
multivesicular body membrane
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: CHMP2B localizes to MVB membranes, supported by IDA evidence from PMID:16554368.
Reason: Core localization for ESCRT-III function. This is the primary site where CHMP2B functions in intraluminal vesicle formation.
|
|
GO:0039702
viral budding via host ESCRT complex
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: CHMP2B participates in viral budding processes, particularly for HIV-1, supported by IDA evidence from PMID:24878737 and IMP from PMID:23051622.
Reason: This is a well-established function of ESCRT-III. The complex is hijacked by retroviruses for viral budding, which is topologically equivalent to MVB intraluminal vesicle formation.
|
|
GO:0043162
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: CHMP2B is essential for MVB-mediated degradation of ubiquitinated cargo proteins, supported by IDA evidence from PMID:17984323.
Reason: Core function of the ESCRT pathway. CHMP2B is required for proper sorting and degradation of ubiquitinated membrane proteins through the MVB pathway.
|
|
GO:0046761
viral budding from plasma membrane
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: CHMP2B participates in viral budding from the plasma membrane, supported by IDA evidence from PMID:24878737.
Reason: HIV-1 and other enveloped viruses bud from the plasma membrane using ESCRT machinery. This is a validated function for ESCRT-III components.
|
|
GO:0061952
midbody abscission
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: CHMP2B is required for the final abscission step of cytokinesis, supported by IMP evidence from PMID:20616062.
Reason: Core function of ESCRT-III. The complex mediates membrane fission at the midbody to complete cell division.
|
|
GO:0071985
multivesicular body sorting pathway
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: CHMP2B is essential for the MVB sorting pathway, supported by IDA evidence from PMID:16554368.
Reason: This is the primary biological process in which CHMP2B functions as an ESCRT-III subunit.
|
|
GO:0097352
autophagosome maturation
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: CHMP2B is required for autophagosome maturation, supported by IMP evidence from PMID:17984323.
Reason: The ESCRT machinery is required for phagophore closure and autophagosome- lysosome fusion. CHMP2B mutations cause defects in autophagy.
|
|
GO:1901673
regulation of mitotic spindle assembly
|
IEA
GO_REF:0000117 |
KEEP AS NON CORE |
Summary: ESCRT-III depletion affects spindle assembly, supported by IMP evidence from PMID:20616062.
Reason: While CHMP2B depletion does affect spindle assembly (PMID:20616062), this is likely a secondary effect of centrosome defects rather than a direct regulatory function.
|
|
GO:1902774
late endosome to lysosome transport
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: CHMP2B is required for late endosome to lysosome transport, supported by IMP evidence from PMID:17984323.
Reason: Core function of ESCRT-III in the endolysosomal pathway. MVB-lysosome fusion requires functional ESCRT machinery.
|
|
GO:1904930
amphisome membrane
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: CHMP2B localizes to amphisome membranes, supported by IDA evidence from PMID:17984323.
Reason: Amphisomes are intermediates between autophagosomes and lysosomes. ESCRT depletion causes accumulation of amphisomes, indicating CHMP2B function at this compartment.
|
|
GO:0005515
protein binding
|
IPI
PMID:16730941 A systematic analysis of human CHMP protein interactions: ad... |
MARK AS OVER ANNOTATED |
Summary: CHMP2B interacts with CHMP3 (PMID:16730941). While protein binding is too general, this reflects specific ESCRT-III complex assembly.
Reason: Protein binding is not informative. The specific interaction with CHMP3 would be better captured as ESCRT-III complex assembly function.
Proposed replacements:
ESCRT III complex
Supporting Evidence:
PMID:16730941
May 30. A systematic analysis of human CHMP protein interactions: additional MIT domain-containing proteins bind to multiple components of the human ESCRT III complex.
|
|
GO:0005515
protein binding
|
IPI
PMID:21044950 Genome-wide YFP fluorescence complementation screen identifi... |
MARK AS OVER ANNOTATED |
Summary: CHMP2B interacts with TERF2IP in a YFP fluorescence complementation screen for telomere signaling regulators.
Reason: Protein binding is not informative. This appears to be a high-throughput screen result without clear functional significance for CHMP2B.
Supporting Evidence:
PMID:21044950
Epub 2010 Nov 2. Genome-wide YFP fluorescence complementation screen identifies new regulators for telomere signaling in human cells.
|
|
GO:0005515
protein binding
|
IPI
PMID:22046132 The SARS-coronavirus-host interactome: identification of cyc... |
MARK AS OVER ANNOTATED |
Summary: CHMP2B interacts with viral Rep proteins based on IntAct data.
Reason: Protein binding is not informative. The viral interaction would be better described in the context of viral budding function.
Supporting Evidence:
PMID:22046132
2011 Oct 27. The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors.
|
|
GO:0005515
protein binding
|
IPI
PMID:23051622 ESCRT-III CHMP2A and CHMP3 form variable helical polymers in... |
MARK AS OVER ANNOTATED |
Summary: CHMP2B interacts with CHMP4B and CHMP3 as part of ESCRT-III assembly during HIV-1 budding.
Reason: Protein binding is not informative. These interactions reflect ESCRT-III complex assembly, better captured by complex membership annotation.
Supporting Evidence:
PMID:23051622
ESCRT-III CHMP2A and CHMP3 form variable helical polymers in vitro and act synergistically during HIV-1 budding.
|
|
GO:0005515
protein binding
|
IPI
PMID:26496610 A human interactome in three quantitative dimensions organiz... |
MARK AS OVER ANNOTATED |
Summary: CHMP2B interacts with CHMP4B in stoichiometry studies.
Reason: Protein binding is not informative. Better captured by ESCRT-III complex membership.
Supporting Evidence:
PMID:26496610
Oct 22. A human interactome in three quantitative dimensions organized by stoichiometries and abundances.
|
|
GO:0000421
autophagosome membrane
|
IDA
PMID:17984323 Functional multivesicular bodies are required for autophagic... |
ACCEPT |
Summary: CHMP2B localizes to autophagosome membranes based on direct observation in cells expressing CHMP2B mutants and controls.
Reason: This localization is functionally relevant as ESCRT machinery is required for phagophore closure during autophagosome formation.
Supporting Evidence:
PMID:17984323
Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease.
|
|
GO:0000776
kinetochore
|
IDA
PMID:26040712 Spastin and ESCRT-III coordinate mitotic spindle disassembly... |
ACCEPT |
Summary: ESCRT-III components localize to kinetochores during mitosis based on immunofluorescence.
Reason: Validated localization that supports the mitotic functions of ESCRT-III.
Supporting Evidence:
PMID:26040712
Spastin and ESCRT-III coordinate mitotic spindle disassembly and nuclear envelope sealing.
|
|
GO:0001778
plasma membrane repair
|
IDA
PMID:24482116 ESCRT machinery is required for plasma membrane repair |
ACCEPT |
Summary: The ESCRT machinery is required for plasma membrane repair based on functional studies.
Reason: ESCRT-III mediates membrane sealing during plasma membrane repair, analogous to its function in other membrane fission events.
Supporting Evidence:
PMID:24482116
2014 Jan 30. ESCRT machinery is required for plasma membrane repair.
|
|
GO:0005765
lysosomal membrane
|
IDA
PMID:17984323 Functional multivesicular bodies are required for autophagic... |
ACCEPT |
Summary: CHMP2B localizes to lysosomal membranes in the context of autophagy and MVB-lysosome fusion.
Reason: Functional localization supporting ESCRT role in endolysosomal trafficking.
Supporting Evidence:
PMID:17984323
Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease.
|
|
GO:0005828
kinetochore microtubule
|
IDA
PMID:26040712 Spastin and ESCRT-III coordinate mitotic spindle disassembly... |
ACCEPT |
Summary: ESCRT-III components localize to kinetochore microtubules during mitosis.
Reason: This localization supports ESCRT-III function in spindle maintenance.
Supporting Evidence:
PMID:26040712
Spastin and ESCRT-III coordinate mitotic spindle disassembly and nuclear envelope sealing.
|
|
GO:0005886
plasma membrane
|
IDA
PMID:24878737 Structure of cellular ESCRT-III spirals and their relationsh... |
ACCEPT |
Summary: CHMP2B localizes to the plasma membrane during viral budding and membrane repair processes.
Reason: Functional localization for ESCRT-III in plasma membrane fission events.
Supporting Evidence:
PMID:24878737
Structure of cellular ESCRT-III spirals and their relationship to HIV budding.
|
|
GO:0006914
autophagy
|
IMP
PMID:17984323 Functional multivesicular bodies are required for autophagic... |
ACCEPT |
Summary: CHMP2B is required for autophagy based on mutant phenotype analysis. CHMP2B mutants cause accumulation of autophagic compartments and protein aggregates.
Reason: This is a core function demonstrated by disease-causing mutations. ESCRT-III is required for autophagosome closure and amphisome-lysosome fusion.
Supporting Evidence:
PMID:17984323
Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease.
|
|
GO:0006997
nucleus organization
|
IMP
PMID:20616062 Human ESCRT-III and VPS4 proteins are required for centrosom... |
KEEP AS NON CORE |
Summary: ESCRT-III depletion causes nuclear morphology defects.
Reason: This is a secondary consequence of defects in nuclear envelope reformation and spindle function rather than a primary regulatory role in nucleus organization.
Supporting Evidence:
PMID:20616062
Human ESCRT-III and VPS4 proteins are required for centrosome and spindle maintenance.
|
|
GO:0007080
mitotic metaphase chromosome alignment
|
IMP
PMID:20616062 Human ESCRT-III and VPS4 proteins are required for centrosom... |
KEEP AS NON CORE |
Summary: ESCRT-III depletion affects chromosome alignment during mitosis.
Reason: This is a secondary consequence of centrosome/spindle defects rather than a direct function in chromosome alignment.
Supporting Evidence:
PMID:20616062
Human ESCRT-III and VPS4 proteins are required for centrosome and spindle maintenance.
|
|
GO:0030496
midbody
|
IDA
PMID:26040712 Spastin and ESCRT-III coordinate mitotic spindle disassembly... |
ACCEPT |
Summary: ESCRT-III components localize to the midbody during cytokinesis based on immunofluorescence.
Reason: Core localization for ESCRT-III function in cytokinetic abscission.
Supporting Evidence:
PMID:26040712
Spastin and ESCRT-III coordinate mitotic spindle disassembly and nuclear envelope sealing.
|
|
GO:0031468
nuclear membrane reassembly
|
IMP
PMID:26040713 ESCRT-III controls nuclear envelope reformation |
ACCEPT |
Summary: CHMP2B is required for nuclear envelope reformation based on functional depletion studies.
Reason: Core function of ESCRT-III in sealing the nuclear envelope during telophase. Well-validated by two independent studies.
Supporting Evidence:
PMID:26040713
ESCRT-III controls nuclear envelope reformation.
|
|
GO:0032585
multivesicular body membrane
|
IDA
PMID:16554368 The ESCRT-III subunit hVps24 is required for degradation but... |
ACCEPT |
Summary: CHMP2B localizes to MVB membranes based on immunofluorescence and functional studies.
Reason: Core localization for ESCRT-III function in MVB biogenesis.
Supporting Evidence:
PMID:16554368
Mar 22. The ESCRT-III subunit hVps24 is required for degradation but not silencing of the epidermal growth factor receptor.
|
|
GO:0036258
multivesicular body assembly
|
NAS
PMID:16505166 Recycling of ESCRTs by the AAA-ATPase Vps4 is regulated by a... |
ACCEPT |
Summary: CHMP2B participates in MVB assembly as an ESCRT-III subunit.
Reason: Core function of ESCRT-III. Well-established through multiple lines of evidence.
Supporting Evidence:
PMID:16505166
Recycling of ESCRTs by the AAA-ATPase Vps4 is regulated by a conserved VSL region in Vta1.
|
|
GO:0039702
viral budding via host ESCRT complex
|
IDA
PMID:24878737 Structure of cellular ESCRT-III spirals and their relationsh... |
ACCEPT |
Summary: CHMP2B is directly visualized forming spirals during HIV budding.
Reason: Direct structural evidence for ESCRT-III function in viral budding.
Supporting Evidence:
PMID:24878737
Structure of cellular ESCRT-III spirals and their relationship to HIV budding.
|
|
GO:0043162
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway
|
IDA
PMID:17984323 Functional multivesicular bodies are required for autophagic... |
ACCEPT |
Summary: CHMP2B is required for MVB-mediated degradation of ubiquitinated proteins based on direct demonstration of cargo accumulation.
Reason: Core function of ESCRT pathway. CHMP2B is essential for sorting ubiquitinated cargo into MVBs for degradation.
Supporting Evidence:
PMID:17984323
Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease.
|
|
GO:0046761
viral budding from plasma membrane
|
IDA
PMID:24878737 Structure of cellular ESCRT-III spirals and their relationsh... |
ACCEPT |
Summary: CHMP2B forms spirals at the plasma membrane during viral budding.
Reason: Direct visualization of ESCRT-III at budding sites on plasma membrane.
Supporting Evidence:
PMID:24878737
Structure of cellular ESCRT-III spirals and their relationship to HIV budding.
|
|
GO:0051469
vesicle fusion with vacuole
|
NAS
PMID:16505166 Recycling of ESCRTs by the AAA-ATPase Vps4 is regulated by a... |
MODIFY |
Summary: CHMP2B participates in MVB-lysosome fusion (mammalian equivalent of vesicle-vacuole fusion).
Reason: In mammalian cells, this process is MVB-lysosome fusion. The term is more appropriate for yeast.
Proposed replacements:
multivesicular body-lysosome fusion
Supporting Evidence:
PMID:16505166
Recycling of ESCRTs by the AAA-ATPase Vps4 is regulated by a conserved VSL region in Vta1.
|
|
GO:0061763
multivesicular body-lysosome fusion
|
NAS
PMID:16505166 Recycling of ESCRTs by the AAA-ATPase Vps4 is regulated by a... |
ACCEPT |
Summary: CHMP2B participates in MVB-lysosome fusion as an ESCRT-III subunit.
Reason: ESCRT-III function is required for efficient MVB-lysosome fusion.
Supporting Evidence:
PMID:16505166
Recycling of ESCRTs by the AAA-ATPase Vps4 is regulated by a conserved VSL region in Vta1.
|
|
GO:0061952
midbody abscission
|
IMP
PMID:20616062 Human ESCRT-III and VPS4 proteins are required for centrosom... |
ACCEPT |
Summary: CHMP2B is required for cytokinetic abscission based on depletion phenotype.
Reason: Core function of ESCRT-III. The complex mediates the final membrane fission step of cytokinesis.
Supporting Evidence:
PMID:20616062
Human ESCRT-III and VPS4 proteins are required for centrosome and spindle maintenance.
|
|
GO:0071985
multivesicular body sorting pathway
|
IDA
PMID:16554368 The ESCRT-III subunit hVps24 is required for degradation but... |
ACCEPT |
Summary: CHMP2B is essential for MVB sorting pathway function.
Reason: Primary biological process for ESCRT-III function.
Supporting Evidence:
PMID:16554368
Mar 22. The ESCRT-III subunit hVps24 is required for degradation but not silencing of the epidermal growth factor receptor.
|
|
GO:0090148
membrane fission
|
NAS
PMID:19234443 Membrane scission by the ESCRT-III complex |
ACCEPT |
Summary: ESCRT-III directly mediates membrane fission based on reconstitution studies.
Reason: Core molecular function of ESCRT-III. The complex drives membrane scission in multiple contexts.
Supporting Evidence:
PMID:19234443
Membrane scission by the ESCRT-III complex.
|
|
GO:0097352
autophagosome maturation
|
IMP
PMID:17984323 Functional multivesicular bodies are required for autophagic... |
ACCEPT |
Summary: CHMP2B is required for autophagosome maturation based on mutant phenotype.
Reason: ESCRT-III is required for phagophore closure and autophagosome- lysosome fusion.
Supporting Evidence:
PMID:17984323
Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease.
|
|
GO:1901673
regulation of mitotic spindle assembly
|
IMP
PMID:20616062 Human ESCRT-III and VPS4 proteins are required for centrosom... |
KEEP AS NON CORE |
Summary: ESCRT-III depletion affects spindle assembly through effects on centrosomes.
Reason: Secondary effect of centrosome defects rather than direct regulatory function.
Supporting Evidence:
PMID:20616062
Human ESCRT-III and VPS4 proteins are required for centrosome and spindle maintenance.
|
|
GO:1902774
late endosome to lysosome transport
|
IMP
PMID:17984323 Functional multivesicular bodies are required for autophagic... |
ACCEPT |
Summary: CHMP2B is required for late endosome to lysosome transport based on cargo accumulation phenotype.
Reason: Core function of ESCRT pathway in endolysosomal trafficking.
Supporting Evidence:
PMID:17984323
Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease.
|
|
GO:1904930
amphisome membrane
|
IDA
PMID:17984323 Functional multivesicular bodies are required for autophagic... |
ACCEPT |
Summary: CHMP2B localizes to amphisome membranes.
Reason: Amphisomes accumulate in ESCRT-depleted cells, indicating ESCRT function at this compartment.
Supporting Evidence:
PMID:17984323
Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease.
|
|
GO:0045296
cadherin binding
|
HDA
PMID:25468996 E-cadherin interactome complexity and robustness resolved by... |
MARK AS OVER ANNOTATED |
Summary: CHMP2B identified in E-cadherin interactome by quantitative proteomics.
Reason: High-throughput data without clear functional significance for CHMP2B core function. May represent transient interaction during membrane trafficking.
Supporting Evidence:
PMID:25468996
E-cadherin interactome complexity and robustness resolved by quantitative proteomics.
|
|
GO:0016236
macroautophagy
|
TAS
PMID:20588296 Membrane budding and scission by the ESCRT machinery: it's a... |
ACCEPT |
Summary: CHMP2B participates in macroautophagy as part of ESCRT-III function.
Reason: ESCRT-III is required for autophagosome closure and maturation.
Supporting Evidence:
PMID:20588296
Jun 30. Membrane budding and scission by the ESCRT machinery: it's all in the neck.
|
|
GO:0061763
multivesicular body-lysosome fusion
|
TAS
PMID:21118109 The role of ESCRT proteins in fusion events involving lysoso... |
ACCEPT |
Summary: CHMP2B participates in MVB-lysosome fusion.
Reason: Core function of ESCRT pathway in endolysosomal trafficking.
Supporting Evidence:
PMID:21118109
The role of ESCRT proteins in fusion events involving lysosomes, endosomes and autophagosomes.
|
|
GO:0005737
cytoplasm
|
IDA
PMID:25468996 E-cadherin interactome complexity and robustness resolved by... |
ACCEPT |
Summary: CHMP2B is detected in the cytoplasm.
Reason: CHMP2B exists in both cytosolic (soluble, inactive) and membrane- associated (active) forms.
Supporting Evidence:
PMID:25468996
E-cadherin interactome complexity and robustness resolved by quantitative proteomics.
|
|
GO:0006914
autophagy
|
TAS
PMID:24095276 Syntaxin 13, a genetic modifier of mutant CHMP2B in frontote... |
ACCEPT |
Summary: CHMP2B is required for autophagy; genetic modifier studies with Syntaxin 13.
Reason: Well-established function of ESCRT-III in autophagy.
Supporting Evidence:
PMID:24095276
2013 Oct 3. Syntaxin 13, a genetic modifier of mutant CHMP2B in frontotemporal dementia, is required for autophagosome maturation.
|
|
GO:0000815
ESCRT III complex
|
TAS
PMID:20588296 Membrane budding and scission by the ESCRT machinery: it's a... |
ACCEPT |
Summary: CHMP2B is a component of ESCRT-III complex.
Reason: Core component of ESCRT-III complex.
Supporting Evidence:
PMID:20588296
Jun 30. Membrane budding and scission by the ESCRT machinery: it's all in the neck.
|
|
GO:0006914
autophagy
|
TAS
PMID:17683935 ESCRT-III dysfunction causes autophagosome accumulation and ... |
ACCEPT |
Summary: CHMP2B is implicated in autophagy.
Reason: Validates ESCRT-III function in autophagy.
Supporting Evidence:
PMID:17683935
2007 Aug 2. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration.
|
|
GO:0036258
multivesicular body assembly
|
TAS
PMID:20588296 Membrane budding and scission by the ESCRT machinery: it's a... |
ACCEPT |
Summary: CHMP2B participates in MVB assembly as part of ESCRT-III.
Reason: Core function of ESCRT-III in MVB biogenesis.
Supporting Evidence:
PMID:20588296
Jun 30. Membrane budding and scission by the ESCRT machinery: it's all in the neck.
|
|
GO:0039702
viral budding via host ESCRT complex
|
TAS
PMID:20588296 Membrane budding and scission by the ESCRT machinery: it's a... |
ACCEPT |
Summary: CHMP2B participates in viral budding via ESCRT.
Reason: Well-established function of ESCRT-III.
Supporting Evidence:
PMID:20588296
Jun 30. Membrane budding and scission by the ESCRT machinery: it's all in the neck.
|
|
GO:1904903
ESCRT III complex disassembly
|
NAS
PMID:20588296 Membrane budding and scission by the ESCRT machinery: it's a... |
ACCEPT |
Summary: CHMP2B is recycled during ESCRT-III complex disassembly by VPS4.
Reason: CHMP2B recruits VPS4 through its MIT-interacting motif for complex disassembly and recycling.
Supporting Evidence:
PMID:20588296
Jun 30. Membrane budding and scission by the ESCRT machinery: it's all in the neck.
|
|
GO:0000815
ESCRT III complex
|
TAS
PMID:21118109 The role of ESCRT proteins in fusion events involving lysoso... |
ACCEPT |
Summary: CHMP2B is a component of ESCRT-III complex.
Reason: Core component of ESCRT-III.
Supporting Evidence:
PMID:21118109
The role of ESCRT proteins in fusion events involving lysosomes, endosomes and autophagosomes.
|
|
GO:0006914
autophagy
|
TAS
PMID:21118109 The role of ESCRT proteins in fusion events involving lysoso... |
ACCEPT |
Summary: CHMP2B is required for autophagy.
Reason: Well-established function.
Supporting Evidence:
PMID:21118109
The role of ESCRT proteins in fusion events involving lysosomes, endosomes and autophagosomes.
|
|
GO:0005515
protein binding
|
IPI
PMID:17683935 ESCRT-III dysfunction causes autophagosome accumulation and ... |
MARK AS OVER ANNOTATED |
Summary: CHMP2B interacts with CHMP2B from mouse (Q9D8B3).
Reason: Protein binding is not informative. This likely reflects homodimerization or ESCRT-III assembly.
Supporting Evidence:
PMID:17683935
2007 Aug 2. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration.
|
|
GO:0000815
ESCRT III complex
|
IDA
PMID:24878737 Structure of cellular ESCRT-III spirals and their relationsh... |
ACCEPT |
Summary: CHMP2B is visualized as part of ESCRT-III spirals by cryo-EM.
Reason: Direct structural evidence for ESCRT-III complex membership.
Supporting Evidence:
PMID:24878737
Structure of cellular ESCRT-III spirals and their relationship to HIV budding.
|
|
GO:0005737
cytoplasm
|
IDA
PMID:24878737 Structure of cellular ESCRT-III spirals and their relationsh... |
ACCEPT |
Summary: CHMP2B detected in cytoplasm by imaging.
Reason: CHMP2B exists in cytoplasmic pool before membrane recruitment.
Supporting Evidence:
PMID:24878737
Structure of cellular ESCRT-III spirals and their relationship to HIV budding.
|
|
GO:0005768
endosome
|
IDA
PMID:24878737 Structure of cellular ESCRT-III spirals and their relationsh... |
ACCEPT |
Summary: CHMP2B colocalizes with endosomes.
Reason: Core localization for ESCRT-III function.
Supporting Evidence:
PMID:24878737
Structure of cellular ESCRT-III spirals and their relationship to HIV budding.
|
|
GO:0019076
viral release from host cell
|
IMP
PMID:23051622 ESCRT-III CHMP2A and CHMP3 form variable helical polymers in... |
ACCEPT |
Summary: CHMP2B is required for HIV-1 release based on depletion phenotype.
Reason: Well-established function of ESCRT-III in viral budding.
Supporting Evidence:
PMID:23051622
ESCRT-III CHMP2A and CHMP3 form variable helical polymers in vitro and act synergistically during HIV-1 budding.
|
|
GO:0019076
viral release from host cell
|
IGI
PMID:23051622 ESCRT-III CHMP2A and CHMP3 form variable helical polymers in... |
ACCEPT |
Summary: CHMP2B functions with CHMP2A and CHMP3 in viral release.
Reason: Genetic interaction data supporting ESCRT-III function in viral budding.
Supporting Evidence:
PMID:23051622
ESCRT-III CHMP2A and CHMP3 form variable helical polymers in vitro and act synergistically during HIV-1 budding.
|
|
GO:0039702
viral budding via host ESCRT complex
|
IMP
PMID:23051622 ESCRT-III CHMP2A and CHMP3 form variable helical polymers in... |
ACCEPT |
Summary: CHMP2B is required for viral budding.
Reason: Direct functional evidence.
Supporting Evidence:
PMID:23051622
ESCRT-III CHMP2A and CHMP3 form variable helical polymers in vitro and act synergistically during HIV-1 budding.
|
|
GO:0070050
neuron cellular homeostasis
|
IMP
PMID:16807408 ALS phenotypes with mutations in CHMP2B (charged multivesicu... |
ACCEPT |
Summary: CHMP2B mutations disrupt neuronal homeostasis, causing ALS/FTD phenotypes.
Reason: Clinically validated function. CHMP2B mutations cause neurodegenerative disease through disruption of neuronal homeostasis.
Supporting Evidence:
PMID:16807408
Epub 2006 Jun 28. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B).
|
|
GO:0005764
lysosome
|
IDA
PMID:16041373 Mutations in the endosomal ESCRTIII-complex subunit CHMP2B i... |
ACCEPT |
Summary: CHMP2B colocalizes with lysosomes.
Reason: Supports ESCRT function in endolysosomal pathway.
Supporting Evidence:
PMID:16041373
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.
|
|
GO:0005770
late endosome
|
IDA
PMID:16041373 Mutations in the endosomal ESCRTIII-complex subunit CHMP2B i... |
ACCEPT |
Summary: CHMP2B colocalizes with late endosomes.
Reason: Core localization for ESCRT-III function.
Supporting Evidence:
PMID:16041373
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.
|
|
GO:0005829
cytosol
|
IDA
PMID:16041373 Mutations in the endosomal ESCRTIII-complex subunit CHMP2B i... |
ACCEPT |
Summary: CHMP2B is present in cytosol.
Reason: Soluble form of CHMP2B before membrane recruitment.
Supporting Evidence:
PMID:16041373
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.
|
|
GO:0007032
endosome organization
|
IMP
PMID:16041373 Mutations in the endosomal ESCRTIII-complex subunit CHMP2B i... |
ACCEPT |
Summary: CHMP2B is required for endosome organization; mutations cause enlarged endosomes.
Reason: Core function of ESCRT-III in endosomal compartment organization.
Supporting Evidence:
PMID:16041373
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.
|
|
GO:0050890
cognition
|
IMP
PMID:16041373 Mutations in the endosomal ESCRTIII-complex subunit CHMP2B i... |
KEEP AS NON CORE |
Summary: CHMP2B mutations affect cognition, causing frontotemporal dementia.
Reason: This is a disease phenotype resulting from disrupted ESCRT function rather than a direct molecular function of CHMP2B. The cognitive deficits arise from neuronal dysfunction secondary to endolysosomal/ autophagy defects.
Supporting Evidence:
PMID:16041373
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.
|
|
GO:0070050
neuron cellular homeostasis
|
IMP
PMID:16041373 Mutations in the endosomal ESCRTIII-complex subunit CHMP2B i... |
ACCEPT |
Summary: CHMP2B is required for neuronal homeostasis.
Reason: Validated by disease phenotypes. ESCRT-III function is essential for neuronal health through its roles in autophagy and endolysosomal trafficking.
Supporting Evidence:
PMID:16041373
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.
|
|
GO:0010824
regulation of centrosome duplication
|
IMP
PMID:20616062 Human ESCRT-III and VPS4 proteins are required for centrosom... |
KEEP AS NON CORE |
Summary: ESCRT-III depletion affects centrosome numbers.
Reason: This appears to be a secondary effect of ESCRT-III depletion rather than a direct regulatory function. The mechanism is unclear.
Supporting Evidence:
PMID:20616062
Human ESCRT-III and VPS4 proteins are required for centrosome and spindle maintenance.
|
|
GO:0039702
viral budding via host ESCRT complex
|
IGI
PMID:24107264 ESCRT requirements for EIAV budding |
ACCEPT |
Summary: CHMP2B functions in EIAV budding via ESCRT.
Reason: Extends viral budding function to other lentiviruses beyond HIV-1.
Supporting Evidence:
PMID:24107264
ESCRT requirements for EIAV budding.
|
|
GO:0070062
extracellular exosome
|
HDA
PMID:23533145 In-depth proteomic analyses of exosomes isolated from expres... |
KEEP AS NON CORE |
Summary: CHMP2B detected in exosome proteomics.
Reason: ESCRT-III may be captured in exosomes during MVB-plasma membrane fusion but is not a core exosome component. This may reflect co-fractionation during exosome biogenesis.
Supporting Evidence:
PMID:23533145
2013 Apr 23. In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
|
|
GO:0005515
protein binding
|
IPI
PMID:21975012 ESCRT-III subunits Snf7-1 and Snf7-2 differentially regulate... |
MARK AS OVER ANNOTATED |
Summary: CHMP2B interacts with CHMP4B.
Reason: Protein binding is not informative. This reflects ESCRT-III complex assembly.
Supporting Evidence:
PMID:21975012
ESCRT-III subunits Snf7-1 and Snf7-2 differentially regulate transmembrane cargos in hESC-derived human neurons.
|
|
GO:0070062
extracellular exosome
|
HDA
PMID:19056867 Large-scale proteomics and phosphoproteomics of urinary exos... |
KEEP AS NON CORE |
Summary: CHMP2B detected in urinary exosome proteomics.
Reason: Same as above - likely co-fractionation during exosome biogenesis.
Supporting Evidence:
PMID:19056867
2008 Dec 3. Large-scale proteomics and phosphoproteomics of urinary exosomes.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-3159232 |
ACCEPT |
Summary: Reactome annotation for HIV virion budding machinery.
Reason: CHMP2B is present in cytosol as part of viral budding pathway.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-917693 |
ACCEPT |
Summary: Reactome annotation for ESCRT disassembly.
Reason: CHMP2B is in cytosol after VPS4-mediated disassembly.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-917700 |
ACCEPT |
Summary: Reactome annotation for MVB vesicle formation.
Reason: CHMP2B cycles between cytosol and membrane.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-9668389 |
ACCEPT |
Summary: Reactome annotation for NE fenestration.
Reason: CHMP2B is in cytosol before recruitment to NE.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-9668395 |
ACCEPT |
Summary: Reactome annotation for CHMP7-CC2D1B binding.
Reason: CHMP2B is in cytosol during this pathway.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-9668398 |
ACCEPT |
Summary: Reactome annotation for CHMP7-CHMP4B binding and ESCRT-III recruitment.
Reason: CHMP2B is in cytosol before membrane recruitment.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-9668405 |
ACCEPT |
Summary: Reactome annotation for spastin binding to IST1.
Reason: CHMP2B is in cytosol during this pathway.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-9668415 |
ACCEPT |
Summary: Reactome annotation for VPS4-mediated ESCRT-III disassembly.
Reason: CHMP2B returns to cytosol after disassembly.
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-9668419 |
ACCEPT |
Summary: Reactome annotation for spastin-mediated microtubule severing.
Reason: CHMP2B is in cytosol during this pathway.
|
|
GO:0019904
protein domain specific binding
|
IPI
PMID:17928862 ESCRT-III recognition by VPS4 ATPases |
ACCEPT |
Summary: CHMP2B binds VPS4A and VPS4B through its MIT-interacting motif.
Reason: Well-characterized domain-specific interaction essential for ESCRT-III recycling. Structural data confirms the MIT-MIM interaction.
Supporting Evidence:
PMID:17928862
ESCRT-III recognition by VPS4 ATPases.
|
|
GO:0180024
membrane grommet activity
|
NAS | NEW |
Summary: Added to align core_functions with existing annotations.
Reason: Core function term not present in existing_annotations.
Supporting Evidence:
PMID:17984323
autophagic degradation is inhibited in cells depleted of ESCRT subunits and in cells expressing CHMP2B mutants
|
Q: What is the precise stoichiometry of CHMP2B within ESCRT-III polymers?
Q: How does K6 methylation by SMYD2 regulate CHMP2B polymerization dynamics?
Q: Are there tissue-specific differences in CHMP2B function that explain selective neuronal vulnerability in FTD/ALS?
Experiment: Structural studies of CHMP2B in the context of full ESCRT-III polymers at near-atomic resolution
Experiment: Live-cell imaging of CHMP2B dynamics during nuclear envelope reformation
Experiment: Proteomics of CHMP2B interactome in neurons versus non-neuronal cells
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Plan overview: We verified the gene/protein identity (CHMP2B, UniProt Q9UQN3), then gathered recent (2023–2024) peer‑reviewed literature on ESCRT‑III function, post‑translational regulation, cellular localizations, and FTD/ALS disease mechanisms, plus clinical biomarker and natural‑history data from the Danish CHMP2B pedigree. We prioritize primary studies and recent reviews, include URLs and publication dates, and cite each major claim.
Comprehensive research report: Human CHMP2B (Q9UQN3)
1) Key concepts and definitions
- Identity and family: CHMP2B (charged multivesicular body protein 2B) is a human ESCRT‑III subunit in the evolutionarily conserved SNF7/ESCRT‑III family that assembles on membranes to remodel and ultimately sever membrane necks; CHMP2B mutations are established genetic causes of familial frontotemporal dementia/ALS (FTD/ALS) (Nucleus, 2024; review) (keeley2024nuclearanddegradative pages 1-3). This places CHMP2B in the ESCRT pathway that drives intraluminal vesicle (ILV) formation in multivesicular bodies (MVBs), membrane repair, and other reverse‑topology scission reactions, with disassembly powered by the AAA+ ATPase VPS4 (Nature Communications, 2024) (richard2024methylationofescrtiii pages 1-2).
- Core ESCRT‑III functions: ESCRT‑III polymers assemble at membrane necks; VPS4 remodels/extracts ESCRT‑III subunits to complete scission. ESCRT‑III operates in MVB biogenesis, cytokinetic abscission, nuclear envelope integrity/repair, plasma membrane and lysosomal repair, and autophagy/lysosome pathways (Nucleus, 2024; review) (keeley2024nuclearanddegradative pages 1-3).
2) Molecular function and regulation; recent developments (2023–2024)
- ESCRT‑III dynamics in cytokinesis and viral budding: A 2024 study identified lysine‑6 methylation of CHMP2B by SMYD2 as a regulator of abscission timing. SMYD2 loss or non‑methylatable CHMP2B K6 mutants delay CHMP2B polymerization and abscission; SMYD2 gain accelerates abscission and can bypass the abscission checkpoint. The same K6 methylation also modulates ESCRT‑III‑dependent HIV‑1 budding (Nature Communications, May 2024; https://doi.org/10.1038/s41467-024-47717-3) (richard2024methylationofescrtiii pages 1-2).
- ESCRT‑III in autophagy/mitophagy: ESCRT‑III is required for sealing phagophores/autophagosomes; depletion of ESCRT‑III subunits (including CHMP2 paralogues) impairs mitophagic flux, consistent with ESCRT‑mediated membrane closure before lysosomal fusion (Autophagy, 2020; context for mechanism cited in 2024 reviews) (keeley2024nuclearanddegradative pages 1-3).
- ESCRT‑III in nuclear envelope and lysosomal/plasma membrane repair: Recent synthesis highlights roles for ESCRT‑III in nuclear pore complex surveillance and nuclear envelope repair, as well as lysosomal membrane damage responses—all processes relevant to neuronal survival (Nucleus, 2024; review; May 2024; https://doi.org/10.1080/19491034.2024.2349085) (keeley2024nuclearanddegradative pages 1-3).
3) Cellular and subcellular localization and where CHMP2B acts
- Endosomes/MVBs and endolysosomal system: Disease‑linked CHMP2B mutations cause enlarged endosomes, endolysosomal trafficking defects, and accumulation of autophagic compartments, locating CHMP2B function at the endosome/MVB–lysosome interface (Nucleus, 2024) (keeley2024nuclearanddegradative pages 9-10).
- Cytokinetic bridge (midbody): CHMP2B is part of ESCRT‑III assemblies at the intercellular bridge, where post‑translational methylation by SMYD2 tunes its polymerization and timing of abscission (Nature Communications, 2024) (richard2024methylationofescrtiii pages 1-2).
- Additional sites in neurons: ESCRT‑III functions in synaptic pruning/trafficking and degradative pathways in neurons; alterations in ESCRT‑III (including CHMP2B) are implicated in synaptic dysfunction in FTD/ALS (Nucleus, 2024; review) (keeley2024nuclearanddegradative pages 1-3).
4) Pathway context and interactions
- ESCRT cascade: Adaptor factors and early ESCRTs nucleate ESCRT‑III assembly. CHMP2B participates in ESCRT‑III heteropolymers that constrict membrane necks, with VPS4 catalyzing remodeling/disassembly to complete scission (Nature Communications, 2024; https://doi.org/10.1038/s41467-024-47717-3) (richard2024methylationofescrtiii pages 1-2). Reviews synthesize CHMP2B within ESCRT‑III roles at endosomes/MVBs, nuclear envelope, and lysosomal repair (Nucleus, 2024) (keeley2024nuclearanddegradative pages 1-3).
5) Disease‑associated mutations and mechanisms (FTD/ALS), with recent primary data
- Spectrum of pathogenic variants: Reviews summarize autosomal dominant C‑terminal truncations (e.g., CHMP2BIntron5/Δ10/Q165X) and point mutations (e.g., D148Y, T104N) causing ESCRT‑III dysfunction (Nucleus, 2024) (keeley2024nuclearanddegradative pages 9-10). A 2023 clinical genetics study reported a novel splice‑site variant (c.532‑2A>T) in CHMP2B in the first Chinese family with CHMP2B‑FTD, predicting truncation that removes part of exon 6; clinical presentation included behavioral onset and frontotemporal atrophy (Mol Genet Genomic Med, Jun 2023; https://doi.org/10.1002/mgg3.2222) (li2023anovelsplice‐site pages 3-4).
- Mutation‑specific cellular phenotypes:
• T104N (associated with ALS‑predominant phenotypes) relocalizes CHMP2B from MVB‑like structures to Golgi‑associated aggregates and inhibits neuronal process elongation; aggregation co‑localizes with GM130 and ubiquitin (Neurology International, Aug 2023; https://doi.org/10.3390/neurolint15030063) (shirai2023ftdalstype7associated pages 4-6).
• D148Y (FTD‑linked) accumulates at the Golgi, triggers Golgi stress signaling (↓Hsp47, ↑Arf4), and blunts neurite elongation; rescuable by Hsp47 overexpression or Arf4 knockdown, nominating Golgi stress modulators as therapeutic targets (Current Issues in Molecular Biology, Feb 2024; https://doi.org/10.3390/cimb46020090) (fukatsu2024modulatinggolgistress pages 1-2).
- Endolysosomal/autophagy dysfunction and proteinopathy: ESCRT‑III impairment by CHMP2B mutations is linked to accumulation of autophagic structures, defective endosome‑to‑lysosome fusion, and lysosomal repair responses; CHMP2B‑FTD often lacks classic cytoplasmic TDP‑43 inclusions despite ubiquitin/p62 pathology (Nucleus, 2024; review) (keeley2024nuclearanddegradative pages 9-10).
6) Clinical biomarkers and natural history (applications and real‑world data)
- CSF endo‑lysosomal/proteostasis markers in a genetically homogeneous Danish pedigree: Targeted PRM‑MS in 31 family members (11 symptomatic, 7 presymptomatic carriers, 13 controls) showed lower CSF ubiquitin, cathepsin B (CTSB), and APP, with higher complement C9, lysozyme, and transcobalamin II (TCN2) in mutation carriers. Some markers correlated with CSF/serum ratios, suggesting peripheral contributions; authors hypothesize intracellular sequestration/altered exosome trafficking as a basis for reduced CSF ubiquitin. Neurofilament light (NfL) rises in CSF/serum several years before onset (Alzheimer’s & Dementia: DADM, Jan 2023; https://doi.org/10.1002/dad2.12402) (toft2023endo‐lysosomalproteinconcentrations pages 1-2, toft2023endo‐lysosomalproteinconcentrations pages 5-6, toft2023endo‐lysosomalproteinconcentrations pages 2-3, toft2023endo‐lysosomalproteinconcentrations pages 6-7).
- Natural history in six generations (Danish FTD‑3 pedigree): Mean age at onset 58.9 years (SD 5.9), mean time from onset to institutionalization 5.7 years (SD 3.7), and to death 10.0 years (SD 7.1), with high variability. Elevated mortality (HR 3.84, p<0.0001). Modifiers included earlier onset with higher education and daily alcohol use; paternal transmission associated with earlier onset in women; ApoE ε4/ε4 associated with delayed institutionalization (Acta Neurol Scand, Jan 2022; https://doi.org/10.1111/ane.13578) (roos2022sixgenerationsof pages 9-13, roos2022sixgenerationsof pages 13-18, roos2022sixgenerationsof pages 1-9).
- Network physiology: EEG microstate analysis (fronto‑parietal network; “microstate D”) showed a biphasic change—prolonged duration early after symptom onset then reduced duration later—consistent with evolving fronto‑parietal network dysfunction in CHMP2B‑FTD (Frontiers in Aging Neuroscience, Sep 2021; https://doi.org/10.3389/fnagi.2021.714220) (musaeus2021corticalfrontoparietalnetwork pages 1-2).
7) Expert opinions and authoritative syntheses (2023–2024)
- 2024 review (Nucleus) emphasizes that ESCRT‑III (including CHMP2B) underpins nuclear envelope surveillance/repair and endolysosomal trafficking in human neurons and that CHMP2B mutations produce truncated proteins, enlarged endosomes, and autophagy defects, clarifying mechanisms for FTD/ALS without canonical TDP‑43 pathology (May 2024; https://doi.org/10.1080/19491034.2024.2349085) (keeley2024nuclearanddegradative pages 1-3, keeley2024nuclearanddegradative pages 9-10).
- 2024 mechanistic advance: CHMP2B K6 methylation by SMYD2 is a tunable PTM that gates ESCRT‑III polymerization and abscission timing, and also affects HIV‑1 budding—providing a new regulatory axis with potential therapeutic leverage (May 2024; Nature Communications; https://doi.org/10.1038/s41467-024-47717-3) (richard2024methylationofescrtiii pages 1-2).
- 2024 autophagy‑lysosome perspective: Autophagy‑lysosomal defects, including those from ESCRT‑III perturbation (e.g., CHMP2B), are central in neurodegeneration and aging brains (Nature Reviews Molecular Cell Biology, Aug 2024; https://doi.org/10.1038/s41580-024-00757-5) (keeley2024nuclearanddegradative pages 1-3).
8) Translational directions and current applications
- Biomarker development: The 2023 CHMP2B family CSF study provides candidate endo‑lysosomal biomarkers (C9, lysozyme, TCN2, ubiquitin, CTSB, APP) for presymptomatic and symptomatic stages, complementing NfL; relationships with CSF/serum ratios guide interpretation of central vs peripheral sources (Alzheimer’s & Dementia: DADM, Jan 2023; https://doi.org/10.1002/dad2.12402) (toft2023endo‐lysosomalproteinconcentrations pages 1-2, toft2023endo‐lysosomalproteinconcentrations pages 5-6).
- Genetic counseling and prognosis: The six‑generation cohort quantifies onset, progression, and survival distributions and potential modifiers, informing counseling and clinical trial design in CHMP2B‑FTD (Acta Neurol Scand, Jan 2022; https://doi.org/10.1111/ane.13578) (roos2022sixgenerationsof pages 9-13, roos2022sixgenerationsof pages 13-18).
- Potential therapeutic targets:
• SMYD2–CHMP2B K6 methylation axis to restore/retime ESCRT‑III polymerization in cytokinesis‑related contexts and potentially in other ESCRT‑dependent neuronal processes (Nature Communications, 2024) (richard2024methylationofescrtiii pages 1-2).
• Golgi stress pathway modifiers (Hsp47 upregulation; Arf4 downregulation) rescue neurite phenotypes induced by FTD‑linked CHMP2B mutants (Current Issues in Molecular Biology, Feb 2024; https://doi.org/10.3390/cimb46020090) (fukatsu2024modulatinggolgistress pages 1-2).
9) Quantitative highlights (recent statistics and data)
- CSF proteomic panel in CHMP2B‑FTD: Relative decreases in ubiquitin, APP, CTSB; increases in complement C9, lysozyme, TCN2; NfL increases years pre‑onset (DADM, Jan 2023) (toft2023endo‐lysosomalproteinconcentrations pages 1-2, toft2023endo‐lysosomalproteinconcentrations pages 5-6, toft2023endo‐lysosomalproteinconcentrations pages 2-3, toft2023endo‐lysosomalproteinconcentrations pages 6-7).
- Natural history metrics in Danish CHMP2B‑FTD: mean age at onset 58.9 years; mean onset→institutionalization 5.7 years; mean onset→death 10.0 years; HR for mortality 3.84 (Acta Neurol Scand, Jan 2022) (roos2022sixgenerationsof pages 9-13, roos2022sixgenerationsof pages 13-18, roos2022sixgenerationsof pages 1-9).
- Neuronal cell biology: CHMP2B T104N mutation shifts localization to Golgi aggregates and impairs neurite outgrowth; D148Y similarly perturbs Golgi stress signaling and morphology, with rescue by Hsp47/Arf4 modulation (Aug 2023; Feb 2024) (shirai2023ftdalstype7associated pages 4-6, fukatsu2024modulatinggolgistress pages 1-2).
10) Verification of identity and domain alignment
- All cited sources explicitly refer to human CHMP2B, an ESCRT‑III/SNF7 family protein operating in the endolysosomal and membrane scission pathways; no evidence was found for conflicting gene symbols/organisms. These align with the UniProt record (Q9UQN3; Homo sapiens; SNF7 family) provided in the prompt (Nucleus, 2024; Human Molecular Genetics, 2020) (keeley2024nuclearanddegradative pages 1-3, fortaznar2020retrovirusreactivationin pages 14-15).
Notes on scope and limitations
- Some mechanistic details (e.g., direct structural data specific to human CHMP2B polymers) are better established for other ESCRT‑III subunits; where needed we referenced authoritative reviews integrating ESCRT‑III assembly mechanisms that include CHMP2B’s role. The 2023–2024 primary advances most directly specific to CHMP2B include K6 methylation (SMYD2) and new mutation‑linked neuronal phenotypes and subcellular mislocalization (T104N, D148Y), plus biomarker and natural‑history data in the Danish pedigree (richard2024methylationofescrtiii pages 1-2, shirai2023ftdalstype7associated pages 4-6, fukatsu2024modulatinggolgistress pages 1-2, toft2023endo‐lysosomalproteinconcentrations pages 1-2, roos2022sixgenerationsof pages 9-13).
References (URLs and dates)
- Keeley O, Coyne AN. Nuclear and degradative functions of the ESCRT‑III pathway: implications for neurodegenerative disease. Nucleus. May 2024. https://doi.org/10.1080/19491034.2024.2349085 (keeley2024nuclearanddegradative pages 1-3, keeley2024nuclearanddegradative pages 9-10).
- Richard A, et al. Methylation of ESCRT‑III components regulates the timing of cytokinetic abscission. Nature Communications. May 2024. https://doi.org/10.1038/s41467-024-47717-3 (richard2024methylationofescrtiii pages 1-2).
- Li C, et al. A novel splice‑site mutation in CHMP2B associated with frontotemporal dementia: The first report from China and literature review. Mol Genet Genomic Med. Jun 2023. https://doi.org/10.1002/mgg3.2222 (li2023anovelsplice‐site pages 3-4).
- Shirai R, et al. FTD/ALS7‑associated Thr104Asn mutation of CHMP2B blunts neuronal process elongation… Neurology International. Aug 2023. https://doi.org/10.3390/neurolint15030063 (shirai2023ftdalstype7associated pages 4-6).
- Fukatsu S, et al. Modulating Golgi Stress Signaling Ameliorates… CHMP2B p.Asp148Tyr. Current Issues in Molecular Biology. Feb 2024. https://doi.org/10.3390/cimb46020090 (fukatsu2024modulatinggolgistress pages 1-2).
- Toft A, et al. Endo‑lysosomal protein concentrations in CSF from patients with FTD caused by CHMP2B mutation. Alzheimer’s & Dementia: DADM. Jan 2023. https://doi.org/10.1002/dad2.12402 (toft2023endo‐lysosomalproteinconcentrations pages 1-2, toft2023endo‐lysosomalproteinconcentrations pages 5-6, toft2023endo‐lysosomalproteinconcentrations pages 2-3, toft2023endo‐lysosomalproteinconcentrations pages 6-7).
- Roos P, et al. Six generations of CHMP2B‑mediated Frontotemporal Dementia: clinical features, progression, and survival. Acta Neurol Scand. Jan 2022. https://doi.org/10.1111/ane.13578 (roos2022sixgenerationsof pages 9-13, roos2022sixgenerationsof pages 13-18, roos2022sixgenerationsof pages 1-9).
- Fort‑Aznar L, Ugbode C, Sweeney ST. Retrovirus reactivation in CHMP2BIntron5 models of FTD. Hum Mol Genet. Jul 2020. https://doi.org/10.1093/hmg/ddaa142 (fortaznar2020retrovirusreactivationin pages 14-15).
References
(keeley2024nuclearanddegradative pages 1-3): Olivia Keeley and Alyssa N. Coyne. Nuclear and degradative functions of the escrt-iii pathway: implications for neurodegenerative disease. Nucleus, May 2024. URL: https://doi.org/10.1080/19491034.2024.2349085, doi:10.1080/19491034.2024.2349085. This article has 12 citations and is from a peer-reviewed journal.
(richard2024methylationofescrtiii pages 1-2): Aurélie Richard, Jérémy Berthelet, Delphine Judith, Tamara Advedissian, Javier Espadas, Guillaume Jannot, Angélique Amo, Damarys Loew, Berangere Lombard, Alexandre G. Casanova, Nicolas Reynoird, Aurélien Roux, Clarisse Berlioz-Torrent, Arnaud Echard, Jonathan B. Weitzman, and Souhila Medjkane. Methylation of escrt-iii components regulates the timing of cytokinetic abscission. Nature Communications, May 2024. URL: https://doi.org/10.1038/s41467-024-47717-3, doi:10.1038/s41467-024-47717-3. This article has 6 citations and is from a highest quality peer-reviewed journal.
(keeley2024nuclearanddegradative pages 9-10): Olivia Keeley and Alyssa N. Coyne. Nuclear and degradative functions of the escrt-iii pathway: implications for neurodegenerative disease. Nucleus, May 2024. URL: https://doi.org/10.1080/19491034.2024.2349085, doi:10.1080/19491034.2024.2349085. This article has 12 citations and is from a peer-reviewed journal.
(li2023anovelsplice‐site pages 3-4): Chang Li, Ya Wen, Mengqiu Zhao, Yaye Wang, Ping Li, Liang Wang, and Shan Wang. A novel splice‐site mutation in chmp2b associated with frontotemporal dementia: the first report from china and literature review. Molecular Genetics & Genomic Medicine, Jun 2023. URL: https://doi.org/10.1002/mgg3.2222, doi:10.1002/mgg3.2222. This article has 2 citations and is from a peer-reviewed journal.
(shirai2023ftdalstype7associated pages 4-6): Remina Shirai, Mizuka Cho, Mikinori Isogai, Shoya Fukatsu, Miyu Okabe, Maho Okawa, Yuki Miyamoto, Tomohiro Torii, and Junji Yamauchi. Ftd/als type 7-associated thr104asn mutation of chmp2b blunts neuronal process elongation, and is recovered by knockdown of arf4, the golgi stress regulator. Neurology International, 15:980-993, Aug 2023. URL: https://doi.org/10.3390/neurolint15030063, doi:10.3390/neurolint15030063. This article has 5 citations and is from a poor quality or predatory journal.
(fukatsu2024modulatinggolgistress pages 1-2): Shoya Fukatsu, Maho Okawa, Miyu Okabe, Mizuka Cho, Mikinori Isogai, Takanori Yokoi, Remina Shirai, Hiroaki Oizumi, Masahiro Yamamoto, Katsuya Ohbuchi, Yuki Miyamoto, and Junji Yamauchi. Modulating golgi stress signaling ameliorates cell morphological phenotypes induced by chmp2b with frontotemporal dementia-associated p.asp148tyr. Current Issues in Molecular Biology, 46:1398-1412, Feb 2024. URL: https://doi.org/10.3390/cimb46020090, doi:10.3390/cimb46020090. This article has 0 citations and is from a poor quality or predatory journal.
(toft2023endo‐lysosomalproteinconcentrations pages 1-2): Anders Toft, Simon Sjödin, Anja Hviid Simonsen, Patrick Ejlerskov, Peter Roos, Christian Sandøe Musaeus, Emil Elbæk Henriksen, Troels Tolstrup Nielsen, Ann Brinkmalm, Kaj Blennow, Henrik Zetterberg, and Jørgen Erik Nielsen. Endo‐lysosomal protein concentrations in csf from patients with frontotemporal dementia caused by chmp2b mutation. Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring, Jan 2023. URL: https://doi.org/10.1002/dad2.12402, doi:10.1002/dad2.12402. This article has 3 citations and is from a peer-reviewed journal.
(toft2023endo‐lysosomalproteinconcentrations pages 5-6): Anders Toft, Simon Sjödin, Anja Hviid Simonsen, Patrick Ejlerskov, Peter Roos, Christian Sandøe Musaeus, Emil Elbæk Henriksen, Troels Tolstrup Nielsen, Ann Brinkmalm, Kaj Blennow, Henrik Zetterberg, and Jørgen Erik Nielsen. Endo‐lysosomal protein concentrations in csf from patients with frontotemporal dementia caused by chmp2b mutation. Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring, Jan 2023. URL: https://doi.org/10.1002/dad2.12402, doi:10.1002/dad2.12402. This article has 3 citations and is from a peer-reviewed journal.
(toft2023endo‐lysosomalproteinconcentrations pages 2-3): Anders Toft, Simon Sjödin, Anja Hviid Simonsen, Patrick Ejlerskov, Peter Roos, Christian Sandøe Musaeus, Emil Elbæk Henriksen, Troels Tolstrup Nielsen, Ann Brinkmalm, Kaj Blennow, Henrik Zetterberg, and Jørgen Erik Nielsen. Endo‐lysosomal protein concentrations in csf from patients with frontotemporal dementia caused by chmp2b mutation. Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring, Jan 2023. URL: https://doi.org/10.1002/dad2.12402, doi:10.1002/dad2.12402. This article has 3 citations and is from a peer-reviewed journal.
(toft2023endo‐lysosomalproteinconcentrations pages 6-7): Anders Toft, Simon Sjödin, Anja Hviid Simonsen, Patrick Ejlerskov, Peter Roos, Christian Sandøe Musaeus, Emil Elbæk Henriksen, Troels Tolstrup Nielsen, Ann Brinkmalm, Kaj Blennow, Henrik Zetterberg, and Jørgen Erik Nielsen. Endo‐lysosomal protein concentrations in csf from patients with frontotemporal dementia caused by chmp2b mutation. Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring, Jan 2023. URL: https://doi.org/10.1002/dad2.12402, doi:10.1002/dad2.12402. This article has 3 citations and is from a peer-reviewed journal.
(roos2022sixgenerationsof pages 9-13): Peter Roos, Peter Johannsen, Suzanne G. Lindquist, Jeremy M. Brown, Gunhild Waldemar, Morten Duno, Troels T. Nielsen, Esben Budtz‐Jørgensen, Susanne Gydesen, Ida E. Holm, John Collinge, Adrian M. Isaacs, Jørgen E. Nielsen, Anders Gade, Jette Stokholm, Tove Thusgaard, Elizabeth M.C. Fisher, and Elisabet Englund. Six generations of chmp2b‐mediated frontotemporal dementia: clinical features, predictive testing, progression, and survival. Acta Neurologica Scandinavica, 145:529-540, Jan 2022. URL: https://doi.org/10.1111/ane.13578, doi:10.1111/ane.13578. This article has 8 citations and is from a peer-reviewed journal.
(roos2022sixgenerationsof pages 13-18): Peter Roos, Peter Johannsen, Suzanne G. Lindquist, Jeremy M. Brown, Gunhild Waldemar, Morten Duno, Troels T. Nielsen, Esben Budtz‐Jørgensen, Susanne Gydesen, Ida E. Holm, John Collinge, Adrian M. Isaacs, Jørgen E. Nielsen, Anders Gade, Jette Stokholm, Tove Thusgaard, Elizabeth M.C. Fisher, and Elisabet Englund. Six generations of chmp2b‐mediated frontotemporal dementia: clinical features, predictive testing, progression, and survival. Acta Neurologica Scandinavica, 145:529-540, Jan 2022. URL: https://doi.org/10.1111/ane.13578, doi:10.1111/ane.13578. This article has 8 citations and is from a peer-reviewed journal.
(roos2022sixgenerationsof pages 1-9): Peter Roos, Peter Johannsen, Suzanne G. Lindquist, Jeremy M. Brown, Gunhild Waldemar, Morten Duno, Troels T. Nielsen, Esben Budtz‐Jørgensen, Susanne Gydesen, Ida E. Holm, John Collinge, Adrian M. Isaacs, Jørgen E. Nielsen, Anders Gade, Jette Stokholm, Tove Thusgaard, Elizabeth M.C. Fisher, and Elisabet Englund. Six generations of chmp2b‐mediated frontotemporal dementia: clinical features, predictive testing, progression, and survival. Acta Neurologica Scandinavica, 145:529-540, Jan 2022. URL: https://doi.org/10.1111/ane.13578, doi:10.1111/ane.13578. This article has 8 citations and is from a peer-reviewed journal.
(musaeus2021corticalfrontoparietalnetwork pages 1-2): C. Musaeus, J. S. Pedersen, T. Kjær, P. Johannsen, G. Waldemar, Maria Joy Normann Haverberg, T. Bacher, J. Nielsen, P. Roos, and S J AM J A E E TT T I Gydesen Brown Isaacs Collinge Gade Englund Fisher. Cortical frontoparietal network dysfunction in chmp2b-frontotemporal dementia. Frontiers in Aging Neuroscience, Sep 2021. URL: https://doi.org/10.3389/fnagi.2021.714220, doi:10.3389/fnagi.2021.714220. This article has 6 citations and is from a peer-reviewed journal.
(fortaznar2020retrovirusreactivationin pages 14-15): Laura Fort-Aznar, Chris Ugbode, and Sean T Sweeney. Retrovirus reactivation in chmp2bintron5 models of frontotemporal dementia. Human Molecular Genetics, 29:2637-2646, Jul 2020. URL: https://doi.org/10.1093/hmg/ddaa142, doi:10.1093/hmg/ddaa142. This article has 10 citations and is from a domain leading peer-reviewed journal.
---
id: Q9UQN3
gene_symbol: CHMP2B
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: CHMP2B (Charged multivesicular body protein 2b) is a core component of
the ESCRT-III (Endosomal Sorting Complex Required for Transport III) machinery,
belonging to the evolutionarily conserved SNF7 family. CHMP2B functions as a structural
subunit that assembles into helical polymers on membranes to mediate reverse-topology
membrane scission events. The protein participates in multiple cellular processes
including multivesicular body (MVB) formation and cargo sorting, cytokinetic abscission
at the midbody, nuclear envelope reformation during telophase, plasma membrane repair,
autophagosome maturation, and viral budding (particularly HIV-1). CHMP2B is recruited
to membrane necks where it cooperates with other ESCRT-III subunits (CHMP4B, CHMP3)
and the AAA ATPase VPS4 for membrane remodeling and fission. Mutations in CHMP2B
cause frontotemporal dementia and/or amyotrophic lateral sclerosis (FTDALS7), demonstrating
the critical importance of ESCRT-III function in neuronal homeostasis. The protein
contains an N-terminal MIT-interacting motif that mediates interaction with VPS4,
and post-translational modifications including K6 methylation by SMYD2 regulate
its polymerization dynamics and abscission timing.
existing_annotations:
- term:
id: GO:0005771
label: multivesicular body
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: CHMP2B is a core ESCRT-III subunit with well-established localization
to multivesicular bodies. This is supported by phylogenetic conservation across
eukaryotes and extensive experimental evidence showing CHMP2B at MVB membranes
(PMID:16554368, PMID:16041373).
action: ACCEPT
reason: Core localization for ESCRT-III function. CHMP2B localizes to MVB membranes
where it participates in intraluminal vesicle formation. The IBA annotation
is well-supported by the phylogenetic analysis and corroborated by multiple
IDA annotations.
supported_by:
- reference_id: file:human/CHMP2B/CHMP2B-deep-research-falcon.md
supporting_text: 'model: Edison Scientific Literature'
- term:
id: GO:0015031
label: protein transport
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: CHMP2B participates in protein transport through its role in the MVB
pathway, which sorts ubiquitinated membrane proteins for lysosomal degradation.
action: ACCEPT
reason: The MVB pathway is fundamentally a protein transport pathway, sorting
ubiquitinated cargo into intraluminal vesicles for subsequent lysosomal degradation.
This is a core function of ESCRT-III components including CHMP2B.
- term:
id: GO:0032509
label: endosome transport via multivesicular body sorting pathway
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: CHMP2B is essential for the MVB sorting pathway, mediating endosomal
cargo transport through its role in intraluminal vesicle formation.
action: ACCEPT
reason: This is a core function of CHMP2B as an ESCRT-III subunit. The protein
is required for the proper formation of intraluminal vesicles within MVBs,
enabling cargo sorting and transport.
- term:
id: GO:0045324
label: late endosome to vacuole transport
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: CHMP2B participates in transport from late endosomes to lysosomes (the
mammalian equivalent of vacuoles) through its role in MVB biogenesis and fusion.
action: ACCEPT
reason: This represents the conserved ESCRT-III function in endolysosomal transport.
The term is appropriate for the mammalian system where lysosomes serve the
function of yeast vacuoles.
- term:
id: GO:0000815
label: ESCRT III complex
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: CHMP2B is a bona fide subunit of the ESCRT-III complex, confirmed by
both phylogenetic analysis and direct biochemical evidence.
action: ACCEPT
reason: CHMP2B is a core ESCRT-III subunit belonging to the SNF7 family. Its
membership in the complex is unequivocally established through structural,
biochemical, and functional studies.
- term:
id: GO:0000776
label: kinetochore
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: ESCRT-III components including CHMP2B have been shown to localize to
kinetochores during mitosis, supported by IDA evidence from PMID:26040712.
action: ACCEPT
reason: This IEA annotation is corroborated by direct experimental evidence
(IDA from PMID:26040712). CHMP2B localizes to kinetochores as part of its
mitotic functions in spindle maintenance and chromosome segregation.
- term:
id: GO:0001778
label: plasma membrane repair
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: ESCRT-III machinery is required for plasma membrane repair, supported
by IDA evidence from PMID:24482116.
action: ACCEPT
reason: This IEA annotation is validated by direct experimental evidence. The
ESCRT machinery performs membrane sealing functions during plasma membrane
repair, analogous to its role in other membrane fission events.
- term:
id: GO:0005643
label: nuclear pore
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: CHMP2B has been detected at nuclear pores as part of ESCRT-III function
in nuclear envelope reformation, though its primary localization is at sites
of annular fusion rather than mature nuclear pores.
action: KEEP_AS_NON_CORE
reason: CHMP2B localizes to nucleo-cytoplasmic channels during nuclear envelope
reformation (PMID:26040713), which are precursors to nuclear pore formation.
However, it is not a stable component of mature nuclear pore complexes. This
is a transient localization related to its membrane sealing function.
- term:
id: GO:0005765
label: lysosomal membrane
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: CHMP2B localizes to lysosomal membranes as part of the endolysosomal
pathway, supported by IDA evidence from PMID:17984323.
action: ACCEPT
reason: The annotation is supported by direct experimental evidence showing
CHMP2B localization to lysosomal membranes in the context of autophagy and
MVB-lysosome fusion.
- term:
id: GO:0005828
label: kinetochore microtubule
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: ESCRT-III components localize to kinetochore microtubules during mitosis,
supported by IDA evidence from PMID:26040712.
action: ACCEPT
reason: This annotation is validated by direct experimental evidence showing
ESCRT-III localization at spindle poles and kinetochore microtubules.
- term:
id: GO:0005829
label: cytosol
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: CHMP2B is present in the cytosol in its soluble, inactive form before
recruitment to membranes.
action: ACCEPT
reason: ESCRT-III proteins exist in an autoinhibited soluble form in the cytosol
and are recruited to membranes upon activation. This is well-established for
CHMP2B.
- term:
id: GO:0007034
label: vacuolar transport
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: InterPro-based annotation reflecting CHMP2B's role in vacuolar/lysosomal
transport as an ESCRT-III subunit.
action: ACCEPT
reason: The SNF7 domain annotation appropriately maps to vacuolar transport
function. In mammalian cells, this corresponds to lysosomal transport pathways.
- term:
id: GO:0007080
label: mitotic metaphase chromosome alignment
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: ESCRT-III depletion affects chromosome alignment during mitosis, supported
by IMP evidence from PMID:20616062.
action: KEEP_AS_NON_CORE
reason: While CHMP2B depletion does affect chromosome alignment (PMID:20616062),
this represents a secondary consequence of centrosome/spindle defects rather
than a direct function. The core ESCRT-III function is membrane remodeling.
- term:
id: GO:0015031
label: protein transport
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: UniProt keyword-based annotation for protein transport, reflecting
CHMP2B's role in sorting and trafficking.
action: ACCEPT
reason: Appropriately broad annotation that captures CHMP2B's role in protein
sorting through the MVB pathway. Duplicates the IBA annotation but from a
different source.
- term:
id: GO:0030496
label: midbody
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: CHMP2B localizes to the midbody during cytokinesis, supported by IDA
evidence from PMID:26040712.
action: ACCEPT
reason: Midbody localization is a core feature of ESCRT-III function in cytokinetic
abscission. Well-validated by direct experimental evidence.
- term:
id: GO:0031468
label: nuclear membrane reassembly
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: CHMP2B participates in nuclear envelope reformation during telophase,
supported by IMP evidence from PMID:26040713.
action: ACCEPT
reason: This is a validated core function of ESCRT-III. The complex is recruited
to sites of annular fusion during nuclear envelope reformation.
- term:
id: GO:0031902
label: late endosome membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: CHMP2B localizes to late endosome membranes as part of the MVB pathway.
action: ACCEPT
reason: Core localization for ESCRT-III function in MVB biogenesis. Late endosomes
are the site of intraluminal vesicle formation.
- term:
id: GO:0032585
label: multivesicular body membrane
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: CHMP2B localizes to MVB membranes, supported by IDA evidence from PMID:16554368.
action: ACCEPT
reason: Core localization for ESCRT-III function. This is the primary site where
CHMP2B functions in intraluminal vesicle formation.
- term:
id: GO:0039702
label: viral budding via host ESCRT complex
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: CHMP2B participates in viral budding processes, particularly for HIV-1,
supported by IDA evidence from PMID:24878737 and IMP from PMID:23051622.
action: ACCEPT
reason: This is a well-established function of ESCRT-III. The complex is hijacked
by retroviruses for viral budding, which is topologically equivalent to MVB
intraluminal vesicle formation.
- term:
id: GO:0043162
label: ubiquitin-dependent protein catabolic process via the multivesicular
body sorting pathway
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: CHMP2B is essential for MVB-mediated degradation of ubiquitinated cargo
proteins, supported by IDA evidence from PMID:17984323.
action: ACCEPT
reason: Core function of the ESCRT pathway. CHMP2B is required for proper sorting
and degradation of ubiquitinated membrane proteins through the MVB pathway.
- term:
id: GO:0046761
label: viral budding from plasma membrane
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: CHMP2B participates in viral budding from the plasma membrane, supported
by IDA evidence from PMID:24878737.
action: ACCEPT
reason: HIV-1 and other enveloped viruses bud from the plasma membrane using
ESCRT machinery. This is a validated function for ESCRT-III components.
- term:
id: GO:0061952
label: midbody abscission
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: CHMP2B is required for the final abscission step of cytokinesis, supported
by IMP evidence from PMID:20616062.
action: ACCEPT
reason: Core function of ESCRT-III. The complex mediates membrane fission at
the midbody to complete cell division.
- term:
id: GO:0071985
label: multivesicular body sorting pathway
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: CHMP2B is essential for the MVB sorting pathway, supported by IDA evidence
from PMID:16554368.
action: ACCEPT
reason: This is the primary biological process in which CHMP2B functions as
an ESCRT-III subunit.
- term:
id: GO:0097352
label: autophagosome maturation
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: CHMP2B is required for autophagosome maturation, supported by IMP evidence
from PMID:17984323.
action: ACCEPT
reason: The ESCRT machinery is required for phagophore closure and autophagosome-
lysosome fusion. CHMP2B mutations cause defects in autophagy.
- term:
id: GO:1901673
label: regulation of mitotic spindle assembly
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: ESCRT-III depletion affects spindle assembly, supported by IMP evidence
from PMID:20616062.
action: KEEP_AS_NON_CORE
reason: While CHMP2B depletion does affect spindle assembly (PMID:20616062),
this is likely a secondary effect of centrosome defects rather than a direct
regulatory function.
- term:
id: GO:1902774
label: late endosome to lysosome transport
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: CHMP2B is required for late endosome to lysosome transport, supported
by IMP evidence from PMID:17984323.
action: ACCEPT
reason: Core function of ESCRT-III in the endolysosomal pathway. MVB-lysosome
fusion requires functional ESCRT machinery.
- term:
id: GO:1904930
label: amphisome membrane
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: CHMP2B localizes to amphisome membranes, supported by IDA evidence
from PMID:17984323.
action: ACCEPT
reason: Amphisomes are intermediates between autophagosomes and lysosomes. ESCRT
depletion causes accumulation of amphisomes, indicating CHMP2B function at
this compartment.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:16730941
review:
summary: CHMP2B interacts with CHMP3 (PMID:16730941). While protein binding
is too general, this reflects specific ESCRT-III complex assembly.
action: MARK_AS_OVER_ANNOTATED
reason: Protein binding is not informative. The specific interaction with CHMP3
would be better captured as ESCRT-III complex assembly function.
proposed_replacement_terms:
- id: GO:0000815
label: ESCRT III complex
supported_by:
- reference_id: PMID:16730941
supporting_text: 'May 30. A systematic analysis of human CHMP protein interactions:
additional MIT domain-containing proteins bind to multiple components
of the human ESCRT III complex.'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:21044950
review:
summary: CHMP2B interacts with TERF2IP in a YFP fluorescence complementation
screen for telomere signaling regulators.
action: MARK_AS_OVER_ANNOTATED
reason: Protein binding is not informative. This appears to be a high-throughput
screen result without clear functional significance for CHMP2B.
supported_by:
- reference_id: PMID:21044950
supporting_text: Epub 2010 Nov 2. Genome-wide YFP fluorescence complementation
screen identifies new regulators for telomere signaling in human cells.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:22046132
review:
summary: CHMP2B interacts with viral Rep proteins based on IntAct data.
action: MARK_AS_OVER_ANNOTATED
reason: Protein binding is not informative. The viral interaction would be better
described in the context of viral budding function.
supported_by:
- reference_id: PMID:22046132
supporting_text: '2011 Oct 27. The SARS-coronavirus-host interactome: identification
of cyclophilins as target for pan-coronavirus inhibitors.'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:23051622
review:
summary: CHMP2B interacts with CHMP4B and CHMP3 as part of ESCRT-III assembly
during HIV-1 budding.
action: MARK_AS_OVER_ANNOTATED
reason: Protein binding is not informative. These interactions reflect ESCRT-III
complex assembly, better captured by complex membership annotation.
supported_by:
- reference_id: PMID:23051622
supporting_text: ESCRT-III CHMP2A and CHMP3 form variable helical polymers
in vitro and act synergistically during HIV-1 budding.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:26496610
review:
summary: CHMP2B interacts with CHMP4B in stoichiometry studies.
action: MARK_AS_OVER_ANNOTATED
reason: Protein binding is not informative. Better captured by ESCRT-III complex
membership.
supported_by:
- reference_id: PMID:26496610
supporting_text: Oct 22. A human interactome in three quantitative dimensions
organized by stoichiometries and abundances.
- term:
id: GO:0000421
label: autophagosome membrane
evidence_type: IDA
original_reference_id: PMID:17984323
review:
summary: CHMP2B localizes to autophagosome membranes based on direct observation
in cells expressing CHMP2B mutants and controls.
action: ACCEPT
reason: This localization is functionally relevant as ESCRT machinery is required
for phagophore closure during autophagosome formation.
supported_by:
- reference_id: PMID:17984323
supporting_text: Functional multivesicular bodies are required for autophagic
clearance of protein aggregates associated with neurodegenerative disease.
- term:
id: GO:0000776
label: kinetochore
evidence_type: IDA
original_reference_id: PMID:26040712
review:
summary: ESCRT-III components localize to kinetochores during mitosis based
on immunofluorescence.
action: ACCEPT
reason: Validated localization that supports the mitotic functions of ESCRT-III.
supported_by:
- reference_id: PMID:26040712
supporting_text: Spastin and ESCRT-III coordinate mitotic spindle disassembly
and nuclear envelope sealing.
- term:
id: GO:0001778
label: plasma membrane repair
evidence_type: IDA
original_reference_id: PMID:24482116
review:
summary: The ESCRT machinery is required for plasma membrane repair based on
functional studies.
action: ACCEPT
reason: ESCRT-III mediates membrane sealing during plasma membrane repair, analogous
to its function in other membrane fission events.
supported_by:
- reference_id: PMID:24482116
supporting_text: 2014 Jan 30. ESCRT machinery is required for plasma membrane
repair.
- term:
id: GO:0005765
label: lysosomal membrane
evidence_type: IDA
original_reference_id: PMID:17984323
review:
summary: CHMP2B localizes to lysosomal membranes in the context of autophagy
and MVB-lysosome fusion.
action: ACCEPT
reason: Functional localization supporting ESCRT role in endolysosomal trafficking.
supported_by:
- reference_id: PMID:17984323
supporting_text: Functional multivesicular bodies are required for autophagic
clearance of protein aggregates associated with neurodegenerative disease.
- term:
id: GO:0005828
label: kinetochore microtubule
evidence_type: IDA
original_reference_id: PMID:26040712
review:
summary: ESCRT-III components localize to kinetochore microtubules during mitosis.
action: ACCEPT
reason: This localization supports ESCRT-III function in spindle maintenance.
supported_by:
- reference_id: PMID:26040712
supporting_text: Spastin and ESCRT-III coordinate mitotic spindle disassembly
and nuclear envelope sealing.
- term:
id: GO:0005886
label: plasma membrane
evidence_type: IDA
original_reference_id: PMID:24878737
review:
summary: CHMP2B localizes to the plasma membrane during viral budding and membrane
repair processes.
action: ACCEPT
reason: Functional localization for ESCRT-III in plasma membrane fission events.
supported_by:
- reference_id: PMID:24878737
supporting_text: Structure of cellular ESCRT-III spirals and their relationship
to HIV budding.
- term:
id: GO:0006914
label: autophagy
evidence_type: IMP
original_reference_id: PMID:17984323
review:
summary: CHMP2B is required for autophagy based on mutant phenotype analysis.
CHMP2B mutants cause accumulation of autophagic compartments and protein aggregates.
action: ACCEPT
reason: This is a core function demonstrated by disease-causing mutations. ESCRT-III
is required for autophagosome closure and amphisome-lysosome fusion.
supported_by:
- reference_id: PMID:17984323
supporting_text: Functional multivesicular bodies are required for autophagic
clearance of protein aggregates associated with neurodegenerative disease.
- term:
id: GO:0006997
label: nucleus organization
evidence_type: IMP
original_reference_id: PMID:20616062
review:
summary: ESCRT-III depletion causes nuclear morphology defects.
action: KEEP_AS_NON_CORE
reason: This is a secondary consequence of defects in nuclear envelope reformation
and spindle function rather than a primary regulatory role in nucleus organization.
supported_by:
- reference_id: PMID:20616062
supporting_text: Human ESCRT-III and VPS4 proteins are required for centrosome
and spindle maintenance.
- term:
id: GO:0007080
label: mitotic metaphase chromosome alignment
evidence_type: IMP
original_reference_id: PMID:20616062
review:
summary: ESCRT-III depletion affects chromosome alignment during mitosis.
action: KEEP_AS_NON_CORE
reason: This is a secondary consequence of centrosome/spindle defects rather
than a direct function in chromosome alignment.
supported_by:
- reference_id: PMID:20616062
supporting_text: Human ESCRT-III and VPS4 proteins are required for centrosome
and spindle maintenance.
- term:
id: GO:0030496
label: midbody
evidence_type: IDA
original_reference_id: PMID:26040712
review:
summary: ESCRT-III components localize to the midbody during cytokinesis based
on immunofluorescence.
action: ACCEPT
reason: Core localization for ESCRT-III function in cytokinetic abscission.
supported_by:
- reference_id: PMID:26040712
supporting_text: Spastin and ESCRT-III coordinate mitotic spindle disassembly
and nuclear envelope sealing.
- term:
id: GO:0031468
label: nuclear membrane reassembly
evidence_type: IMP
original_reference_id: PMID:26040713
review:
summary: CHMP2B is required for nuclear envelope reformation based on functional
depletion studies.
action: ACCEPT
reason: Core function of ESCRT-III in sealing the nuclear envelope during telophase.
Well-validated by two independent studies.
supported_by:
- reference_id: PMID:26040713
supporting_text: ESCRT-III controls nuclear envelope reformation.
- term:
id: GO:0032585
label: multivesicular body membrane
evidence_type: IDA
original_reference_id: PMID:16554368
review:
summary: CHMP2B localizes to MVB membranes based on immunofluorescence and functional
studies.
action: ACCEPT
reason: Core localization for ESCRT-III function in MVB biogenesis.
supported_by:
- reference_id: PMID:16554368
supporting_text: Mar 22. The ESCRT-III subunit hVps24 is required for degradation
but not silencing of the epidermal growth factor receptor.
- term:
id: GO:0036258
label: multivesicular body assembly
evidence_type: NAS
original_reference_id: PMID:16505166
review:
summary: CHMP2B participates in MVB assembly as an ESCRT-III subunit.
action: ACCEPT
reason: Core function of ESCRT-III. Well-established through multiple lines
of evidence.
supported_by:
- reference_id: PMID:16505166
supporting_text: Recycling of ESCRTs by the AAA-ATPase Vps4 is regulated
by a conserved VSL region in Vta1.
- term:
id: GO:0039702
label: viral budding via host ESCRT complex
evidence_type: IDA
original_reference_id: PMID:24878737
review:
summary: CHMP2B is directly visualized forming spirals during HIV budding.
action: ACCEPT
reason: Direct structural evidence for ESCRT-III function in viral budding.
supported_by:
- reference_id: PMID:24878737
supporting_text: Structure of cellular ESCRT-III spirals and their relationship
to HIV budding.
- term:
id: GO:0043162
label: ubiquitin-dependent protein catabolic process via the multivesicular
body sorting pathway
evidence_type: IDA
original_reference_id: PMID:17984323
review:
summary: CHMP2B is required for MVB-mediated degradation of ubiquitinated proteins
based on direct demonstration of cargo accumulation.
action: ACCEPT
reason: Core function of ESCRT pathway. CHMP2B is essential for sorting ubiquitinated
cargo into MVBs for degradation.
supported_by:
- reference_id: PMID:17984323
supporting_text: Functional multivesicular bodies are required for autophagic
clearance of protein aggregates associated with neurodegenerative disease.
- term:
id: GO:0046761
label: viral budding from plasma membrane
evidence_type: IDA
original_reference_id: PMID:24878737
review:
summary: CHMP2B forms spirals at the plasma membrane during viral budding.
action: ACCEPT
reason: Direct visualization of ESCRT-III at budding sites on plasma membrane.
supported_by:
- reference_id: PMID:24878737
supporting_text: Structure of cellular ESCRT-III spirals and their relationship
to HIV budding.
- term:
id: GO:0051469
label: vesicle fusion with vacuole
evidence_type: NAS
original_reference_id: PMID:16505166
review:
summary: CHMP2B participates in MVB-lysosome fusion (mammalian equivalent of
vesicle-vacuole fusion).
action: MODIFY
reason: In mammalian cells, this process is MVB-lysosome fusion. The term is
more appropriate for yeast.
proposed_replacement_terms:
- id: GO:0061763
label: multivesicular body-lysosome fusion
supported_by:
- reference_id: PMID:16505166
supporting_text: Recycling of ESCRTs by the AAA-ATPase Vps4 is regulated
by a conserved VSL region in Vta1.
- term:
id: GO:0061763
label: multivesicular body-lysosome fusion
evidence_type: NAS
original_reference_id: PMID:16505166
review:
summary: CHMP2B participates in MVB-lysosome fusion as an ESCRT-III subunit.
action: ACCEPT
reason: ESCRT-III function is required for efficient MVB-lysosome fusion.
supported_by:
- reference_id: PMID:16505166
supporting_text: Recycling of ESCRTs by the AAA-ATPase Vps4 is regulated
by a conserved VSL region in Vta1.
- term:
id: GO:0061952
label: midbody abscission
evidence_type: IMP
original_reference_id: PMID:20616062
review:
summary: CHMP2B is required for cytokinetic abscission based on depletion phenotype.
action: ACCEPT
reason: Core function of ESCRT-III. The complex mediates the final membrane
fission step of cytokinesis.
supported_by:
- reference_id: PMID:20616062
supporting_text: Human ESCRT-III and VPS4 proteins are required for centrosome
and spindle maintenance.
- term:
id: GO:0071985
label: multivesicular body sorting pathway
evidence_type: IDA
original_reference_id: PMID:16554368
review:
summary: CHMP2B is essential for MVB sorting pathway function.
action: ACCEPT
reason: Primary biological process for ESCRT-III function.
supported_by:
- reference_id: PMID:16554368
supporting_text: Mar 22. The ESCRT-III subunit hVps24 is required for degradation
but not silencing of the epidermal growth factor receptor.
- term:
id: GO:0090148
label: membrane fission
evidence_type: NAS
original_reference_id: PMID:19234443
review:
summary: ESCRT-III directly mediates membrane fission based on reconstitution
studies.
action: ACCEPT
reason: Core molecular function of ESCRT-III. The complex drives membrane scission
in multiple contexts.
supported_by:
- reference_id: PMID:19234443
supporting_text: Membrane scission by the ESCRT-III complex.
- term:
id: GO:0097352
label: autophagosome maturation
evidence_type: IMP
original_reference_id: PMID:17984323
review:
summary: CHMP2B is required for autophagosome maturation based on mutant phenotype.
action: ACCEPT
reason: ESCRT-III is required for phagophore closure and autophagosome- lysosome
fusion.
supported_by:
- reference_id: PMID:17984323
supporting_text: Functional multivesicular bodies are required for autophagic
clearance of protein aggregates associated with neurodegenerative disease.
- term:
id: GO:1901673
label: regulation of mitotic spindle assembly
evidence_type: IMP
original_reference_id: PMID:20616062
review:
summary: ESCRT-III depletion affects spindle assembly through effects on centrosomes.
action: KEEP_AS_NON_CORE
reason: Secondary effect of centrosome defects rather than direct regulatory
function.
supported_by:
- reference_id: PMID:20616062
supporting_text: Human ESCRT-III and VPS4 proteins are required for centrosome
and spindle maintenance.
- term:
id: GO:1902774
label: late endosome to lysosome transport
evidence_type: IMP
original_reference_id: PMID:17984323
review:
summary: CHMP2B is required for late endosome to lysosome transport based on
cargo accumulation phenotype.
action: ACCEPT
reason: Core function of ESCRT pathway in endolysosomal trafficking.
supported_by:
- reference_id: PMID:17984323
supporting_text: Functional multivesicular bodies are required for autophagic
clearance of protein aggregates associated with neurodegenerative disease.
- term:
id: GO:1904930
label: amphisome membrane
evidence_type: IDA
original_reference_id: PMID:17984323
review:
summary: CHMP2B localizes to amphisome membranes.
action: ACCEPT
reason: Amphisomes accumulate in ESCRT-depleted cells, indicating ESCRT function
at this compartment.
supported_by:
- reference_id: PMID:17984323
supporting_text: Functional multivesicular bodies are required for autophagic
clearance of protein aggregates associated with neurodegenerative disease.
- term:
id: GO:0045296
label: cadherin binding
evidence_type: HDA
original_reference_id: PMID:25468996
review:
summary: CHMP2B identified in E-cadherin interactome by quantitative proteomics.
action: MARK_AS_OVER_ANNOTATED
reason: High-throughput data without clear functional significance for CHMP2B
core function. May represent transient interaction during membrane trafficking.
supported_by:
- reference_id: PMID:25468996
supporting_text: E-cadherin interactome complexity and robustness resolved
by quantitative proteomics.
- term:
id: GO:0016236
label: macroautophagy
evidence_type: TAS
original_reference_id: PMID:20588296
review:
summary: CHMP2B participates in macroautophagy as part of ESCRT-III function.
action: ACCEPT
reason: ESCRT-III is required for autophagosome closure and maturation.
supported_by:
- reference_id: PMID:20588296
supporting_text: "Jun 30. Membrane budding and scission by the ESCRT machinery:\
\ it's all in the neck."
- term:
id: GO:0061763
label: multivesicular body-lysosome fusion
evidence_type: TAS
original_reference_id: PMID:21118109
review:
summary: CHMP2B participates in MVB-lysosome fusion.
action: ACCEPT
reason: Core function of ESCRT pathway in endolysosomal trafficking.
supported_by:
- reference_id: PMID:21118109
supporting_text: The role of ESCRT proteins in fusion events involving lysosomes,
endosomes and autophagosomes.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:25468996
review:
summary: CHMP2B is detected in the cytoplasm.
action: ACCEPT
reason: CHMP2B exists in both cytosolic (soluble, inactive) and membrane- associated
(active) forms.
supported_by:
- reference_id: PMID:25468996
supporting_text: E-cadherin interactome complexity and robustness resolved
by quantitative proteomics.
- term:
id: GO:0006914
label: autophagy
evidence_type: TAS
original_reference_id: PMID:24095276
review:
summary: CHMP2B is required for autophagy; genetic modifier studies with Syntaxin
13.
action: ACCEPT
reason: Well-established function of ESCRT-III in autophagy.
supported_by:
- reference_id: PMID:24095276
supporting_text: 2013 Oct 3. Syntaxin 13, a genetic modifier of mutant CHMP2B
in frontotemporal dementia, is required for autophagosome maturation.
- term:
id: GO:0000815
label: ESCRT III complex
evidence_type: TAS
original_reference_id: PMID:20588296
review:
summary: CHMP2B is a component of ESCRT-III complex.
action: ACCEPT
reason: Core component of ESCRT-III complex.
supported_by:
- reference_id: PMID:20588296
supporting_text: "Jun 30. Membrane budding and scission by the ESCRT machinery:\
\ it's all in the neck."
- term:
id: GO:0006914
label: autophagy
evidence_type: TAS
original_reference_id: PMID:17683935
review:
summary: CHMP2B is implicated in autophagy.
action: ACCEPT
reason: Validates ESCRT-III function in autophagy.
supported_by:
- reference_id: PMID:17683935
supporting_text: 2007 Aug 2. ESCRT-III dysfunction causes autophagosome
accumulation and neurodegeneration.
- term:
id: GO:0036258
label: multivesicular body assembly
evidence_type: TAS
original_reference_id: PMID:20588296
review:
summary: CHMP2B participates in MVB assembly as part of ESCRT-III.
action: ACCEPT
reason: Core function of ESCRT-III in MVB biogenesis.
supported_by:
- reference_id: PMID:20588296
supporting_text: "Jun 30. Membrane budding and scission by the ESCRT machinery:\
\ it's all in the neck."
- term:
id: GO:0039702
label: viral budding via host ESCRT complex
evidence_type: TAS
original_reference_id: PMID:20588296
review:
summary: CHMP2B participates in viral budding via ESCRT.
action: ACCEPT
reason: Well-established function of ESCRT-III.
supported_by:
- reference_id: PMID:20588296
supporting_text: "Jun 30. Membrane budding and scission by the ESCRT machinery:\
\ it's all in the neck."
- term:
id: GO:1904903
label: ESCRT III complex disassembly
evidence_type: NAS
original_reference_id: PMID:20588296
review:
summary: CHMP2B is recycled during ESCRT-III complex disassembly by VPS4.
action: ACCEPT
reason: CHMP2B recruits VPS4 through its MIT-interacting motif for complex disassembly
and recycling.
supported_by:
- reference_id: PMID:20588296
supporting_text: "Jun 30. Membrane budding and scission by the ESCRT machinery:\
\ it's all in the neck."
- term:
id: GO:0000815
label: ESCRT III complex
evidence_type: TAS
original_reference_id: PMID:21118109
review:
summary: CHMP2B is a component of ESCRT-III complex.
action: ACCEPT
reason: Core component of ESCRT-III.
supported_by:
- reference_id: PMID:21118109
supporting_text: The role of ESCRT proteins in fusion events involving lysosomes,
endosomes and autophagosomes.
- term:
id: GO:0006914
label: autophagy
evidence_type: TAS
original_reference_id: PMID:21118109
review:
summary: CHMP2B is required for autophagy.
action: ACCEPT
reason: Well-established function.
supported_by:
- reference_id: PMID:21118109
supporting_text: The role of ESCRT proteins in fusion events involving lysosomes,
endosomes and autophagosomes.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:17683935
review:
summary: CHMP2B interacts with CHMP2B from mouse (Q9D8B3).
action: MARK_AS_OVER_ANNOTATED
reason: Protein binding is not informative. This likely reflects homodimerization
or ESCRT-III assembly.
supported_by:
- reference_id: PMID:17683935
supporting_text: 2007 Aug 2. ESCRT-III dysfunction causes autophagosome
accumulation and neurodegeneration.
- term:
id: GO:0000815
label: ESCRT III complex
evidence_type: IDA
original_reference_id: PMID:24878737
review:
summary: CHMP2B is visualized as part of ESCRT-III spirals by cryo-EM.
action: ACCEPT
reason: Direct structural evidence for ESCRT-III complex membership.
supported_by:
- reference_id: PMID:24878737
supporting_text: Structure of cellular ESCRT-III spirals and their relationship
to HIV budding.
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IDA
original_reference_id: PMID:24878737
review:
summary: CHMP2B detected in cytoplasm by imaging.
action: ACCEPT
reason: CHMP2B exists in cytoplasmic pool before membrane recruitment.
supported_by:
- reference_id: PMID:24878737
supporting_text: Structure of cellular ESCRT-III spirals and their relationship
to HIV budding.
- term:
id: GO:0005768
label: endosome
evidence_type: IDA
original_reference_id: PMID:24878737
review:
summary: CHMP2B colocalizes with endosomes.
action: ACCEPT
reason: Core localization for ESCRT-III function.
supported_by:
- reference_id: PMID:24878737
supporting_text: Structure of cellular ESCRT-III spirals and their relationship
to HIV budding.
- term:
id: GO:0019076
label: viral release from host cell
evidence_type: IMP
original_reference_id: PMID:23051622
review:
summary: CHMP2B is required for HIV-1 release based on depletion phenotype.
action: ACCEPT
reason: Well-established function of ESCRT-III in viral budding.
supported_by:
- reference_id: PMID:23051622
supporting_text: ESCRT-III CHMP2A and CHMP3 form variable helical polymers
in vitro and act synergistically during HIV-1 budding.
- term:
id: GO:0019076
label: viral release from host cell
evidence_type: IGI
original_reference_id: PMID:23051622
review:
summary: CHMP2B functions with CHMP2A and CHMP3 in viral release.
action: ACCEPT
reason: Genetic interaction data supporting ESCRT-III function in viral budding.
supported_by:
- reference_id: PMID:23051622
supporting_text: ESCRT-III CHMP2A and CHMP3 form variable helical polymers
in vitro and act synergistically during HIV-1 budding.
- term:
id: GO:0039702
label: viral budding via host ESCRT complex
evidence_type: IMP
original_reference_id: PMID:23051622
review:
summary: CHMP2B is required for viral budding.
action: ACCEPT
reason: Direct functional evidence.
supported_by:
- reference_id: PMID:23051622
supporting_text: ESCRT-III CHMP2A and CHMP3 form variable helical polymers
in vitro and act synergistically during HIV-1 budding.
- term:
id: GO:0070050
label: neuron cellular homeostasis
evidence_type: IMP
original_reference_id: PMID:16807408
review:
summary: CHMP2B mutations disrupt neuronal homeostasis, causing ALS/FTD phenotypes.
action: ACCEPT
reason: Clinically validated function. CHMP2B mutations cause neurodegenerative
disease through disruption of neuronal homeostasis.
supported_by:
- reference_id: PMID:16807408
supporting_text: Epub 2006 Jun 28. ALS phenotypes with mutations in CHMP2B
(charged multivesicular body protein 2B).
- term:
id: GO:0005764
label: lysosome
evidence_type: IDA
original_reference_id: PMID:16041373
review:
summary: CHMP2B colocalizes with lysosomes.
action: ACCEPT
reason: Supports ESCRT function in endolysosomal pathway.
supported_by:
- reference_id: PMID:16041373
supporting_text: Mutations in the endosomal ESCRTIII-complex subunit CHMP2B
in frontotemporal dementia.
- term:
id: GO:0005770
label: late endosome
evidence_type: IDA
original_reference_id: PMID:16041373
review:
summary: CHMP2B colocalizes with late endosomes.
action: ACCEPT
reason: Core localization for ESCRT-III function.
supported_by:
- reference_id: PMID:16041373
supporting_text: Mutations in the endosomal ESCRTIII-complex subunit CHMP2B
in frontotemporal dementia.
- term:
id: GO:0005829
label: cytosol
evidence_type: IDA
original_reference_id: PMID:16041373
review:
summary: CHMP2B is present in cytosol.
action: ACCEPT
reason: Soluble form of CHMP2B before membrane recruitment.
supported_by:
- reference_id: PMID:16041373
supporting_text: Mutations in the endosomal ESCRTIII-complex subunit CHMP2B
in frontotemporal dementia.
- term:
id: GO:0007032
label: endosome organization
evidence_type: IMP
original_reference_id: PMID:16041373
review:
summary: CHMP2B is required for endosome organization; mutations cause enlarged
endosomes.
action: ACCEPT
reason: Core function of ESCRT-III in endosomal compartment organization.
supported_by:
- reference_id: PMID:16041373
supporting_text: Mutations in the endosomal ESCRTIII-complex subunit CHMP2B
in frontotemporal dementia.
- term:
id: GO:0050890
label: cognition
evidence_type: IMP
original_reference_id: PMID:16041373
review:
summary: CHMP2B mutations affect cognition, causing frontotemporal dementia.
action: KEEP_AS_NON_CORE
reason: This is a disease phenotype resulting from disrupted ESCRT function
rather than a direct molecular function of CHMP2B. The cognitive deficits
arise from neuronal dysfunction secondary to endolysosomal/ autophagy defects.
supported_by:
- reference_id: PMID:16041373
supporting_text: Mutations in the endosomal ESCRTIII-complex subunit CHMP2B
in frontotemporal dementia.
- term:
id: GO:0070050
label: neuron cellular homeostasis
evidence_type: IMP
original_reference_id: PMID:16041373
review:
summary: CHMP2B is required for neuronal homeostasis.
action: ACCEPT
reason: Validated by disease phenotypes. ESCRT-III function is essential for
neuronal health through its roles in autophagy and endolysosomal trafficking.
supported_by:
- reference_id: PMID:16041373
supporting_text: Mutations in the endosomal ESCRTIII-complex subunit CHMP2B
in frontotemporal dementia.
- term:
id: GO:0010824
label: regulation of centrosome duplication
evidence_type: IMP
original_reference_id: PMID:20616062
review:
summary: ESCRT-III depletion affects centrosome numbers.
action: KEEP_AS_NON_CORE
reason: This appears to be a secondary effect of ESCRT-III depletion rather
than a direct regulatory function. The mechanism is unclear.
supported_by:
- reference_id: PMID:20616062
supporting_text: Human ESCRT-III and VPS4 proteins are required for centrosome
and spindle maintenance.
- term:
id: GO:0039702
label: viral budding via host ESCRT complex
evidence_type: IGI
original_reference_id: PMID:24107264
review:
summary: CHMP2B functions in EIAV budding via ESCRT.
action: ACCEPT
reason: Extends viral budding function to other lentiviruses beyond HIV-1.
supported_by:
- reference_id: PMID:24107264
supporting_text: ESCRT requirements for EIAV budding.
- term:
id: GO:0070062
label: extracellular exosome
evidence_type: HDA
original_reference_id: PMID:23533145
review:
summary: CHMP2B detected in exosome proteomics.
action: KEEP_AS_NON_CORE
reason: ESCRT-III may be captured in exosomes during MVB-plasma membrane fusion
but is not a core exosome component. This may reflect co-fractionation during
exosome biogenesis.
supported_by:
- reference_id: PMID:23533145
supporting_text: 2013 Apr 23. In-depth proteomic analyses of exosomes isolated
from expressed prostatic secretions in urine.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:21975012
review:
summary: CHMP2B interacts with CHMP4B.
action: MARK_AS_OVER_ANNOTATED
reason: Protein binding is not informative. This reflects ESCRT-III complex
assembly.
supported_by:
- reference_id: PMID:21975012
supporting_text: ESCRT-III subunits Snf7-1 and Snf7-2 differentially regulate
transmembrane cargos in hESC-derived human neurons.
- term:
id: GO:0070062
label: extracellular exosome
evidence_type: HDA
original_reference_id: PMID:19056867
review:
summary: CHMP2B detected in urinary exosome proteomics.
action: KEEP_AS_NON_CORE
reason: Same as above - likely co-fractionation during exosome biogenesis.
supported_by:
- reference_id: PMID:19056867
supporting_text: 2008 Dec 3. Large-scale proteomics and phosphoproteomics
of urinary exosomes.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-3159232
review:
summary: Reactome annotation for HIV virion budding machinery.
action: ACCEPT
reason: CHMP2B is present in cytosol as part of viral budding pathway.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-917693
review:
summary: Reactome annotation for ESCRT disassembly.
action: ACCEPT
reason: CHMP2B is in cytosol after VPS4-mediated disassembly.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-917700
review:
summary: Reactome annotation for MVB vesicle formation.
action: ACCEPT
reason: CHMP2B cycles between cytosol and membrane.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9668389
review:
summary: Reactome annotation for NE fenestration.
action: ACCEPT
reason: CHMP2B is in cytosol before recruitment to NE.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9668395
review:
summary: Reactome annotation for CHMP7-CC2D1B binding.
action: ACCEPT
reason: CHMP2B is in cytosol during this pathway.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9668398
review:
summary: Reactome annotation for CHMP7-CHMP4B binding and ESCRT-III recruitment.
action: ACCEPT
reason: CHMP2B is in cytosol before membrane recruitment.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9668405
review:
summary: Reactome annotation for spastin binding to IST1.
action: ACCEPT
reason: CHMP2B is in cytosol during this pathway.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9668415
review:
summary: Reactome annotation for VPS4-mediated ESCRT-III disassembly.
action: ACCEPT
reason: CHMP2B returns to cytosol after disassembly.
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9668419
review:
summary: Reactome annotation for spastin-mediated microtubule severing.
action: ACCEPT
reason: CHMP2B is in cytosol during this pathway.
- term:
id: GO:0019904
label: protein domain specific binding
evidence_type: IPI
original_reference_id: PMID:17928862
review:
summary: CHMP2B binds VPS4A and VPS4B through its MIT-interacting motif.
action: ACCEPT
reason: Well-characterized domain-specific interaction essential for ESCRT-III
recycling. Structural data confirms the MIT-MIM interaction.
supported_by:
- reference_id: PMID:17928862
supporting_text: ESCRT-III recognition by VPS4 ATPases.
- term:
id: GO:0180024
label: membrane grommet activity
evidence_type: NAS
review:
summary: Added to align core_functions with existing annotations.
action: NEW
reason: Core function term not present in existing_annotations.
supported_by:
- reference_id: PMID:17984323
supporting_text: autophagic degradation is inhibited in cells depleted of
ESCRT subunits and in cells expressing CHMP2B mutants
core_functions:
- molecular_function:
id: GO:0180024
label: membrane grommet activity
directly_involved_in:
- id: GO:0071985
label: multivesicular body sorting pathway
locations:
- id: GO:0005771
label: multivesicular body
- id: GO:0032585
label: multivesicular body membrane
in_complex:
id: GO:0000815
label: ESCRT III complex
description: CHMP2B is a core subunit of the ESCRT-III complex that mediates membrane
fission during intraluminal vesicle formation in MVBs.
supported_by:
- reference_id: PMID:19234443
supporting_text: Three subunits of ESCRT-III, Vps20, Snf7, and Vps24, were
sufficient to detach intralumenal vesicles
- molecular_function:
id: GO:0180024
label: membrane grommet activity
directly_involved_in:
- id: GO:0061952
label: midbody abscission
locations:
- id: GO:0030496
label: midbody
in_complex:
id: GO:0000815
label: ESCRT III complex
description: CHMP2B performs membrane fission at the midbody during cytokinetic
abscission.
supported_by:
- reference_id: PMID:20616062
supporting_text: depletion of VPS4A, VPS4B, or any of the 11 different human
ESCRT-III (CHMP) proteins inhibited abscission
- molecular_function:
id: GO:0180024
label: membrane grommet activity
directly_involved_in:
- id: GO:0031468
label: nuclear membrane reassembly
in_complex:
id: GO:0000815
label: ESCRT III complex
description: CHMP2B mediates membrane sealing during nuclear envelope reformation
at telophase.
supported_by:
- reference_id: PMID:26040713
supporting_text: the endosomal sorting complex required for transport-III
(ESCRT-III) machinery localizes to sites of annular fusion in the forming
NE in human cells
- molecular_function:
id: GO:0180024
label: membrane grommet activity
directly_involved_in:
- id: GO:0039702
label: viral budding via host ESCRT complex
locations:
- id: GO:0005886
label: plasma membrane
in_complex:
id: GO:0000815
label: ESCRT III complex
description: CHMP2B mediates membrane fission during viral budding at the plasma
membrane.
supported_by:
- reference_id: PMID:24878737
supporting_text: Structure of cellular ESCRT-III spirals and their relationship
to HIV budding
- molecular_function:
id: GO:0180024
label: membrane grommet activity
directly_involved_in:
- id: GO:0097352
label: autophagosome maturation
locations:
- id: GO:0000421
label: autophagosome membrane
in_complex:
id: GO:0000815
label: ESCRT III complex
description: CHMP2B mediates membrane sealing during phagophore closure.
supported_by:
- reference_id: PMID:17984323
supporting_text: autophagic degradation is inhibited in cells depleted of
ESCRT subunits and in cells expressing CHMP2B mutants
- molecular_function:
id: GO:0019904
label: protein domain specific binding
directly_involved_in:
- id: GO:1904903
label: ESCRT III complex disassembly
locations:
- id: GO:0005829
label: cytosol
in_complex:
id: GO:0000815
label: ESCRT III complex
description: CHMP2B binds VPS4 ATPases through its MIT-interacting motif (MIM),
enabling ESCRT-III complex disassembly.
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings:
- statement: CHMP2B contains the Snf7 domain which maps to vacuolar transport
function
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings:
- statement: CHMP2B function as an ESCRT-III subunit is conserved across eukaryotes
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
findings:
- statement: Protein transport keyword maps to GO:0015031
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping
findings:
- statement: CHMP2B subcellular location annotations derived from UniProt
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings:
- statement: ARBA predictions for CHMP2B localization and function generally
accurate
- id: PMID:16041373
title: Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal
dementia
findings:
- statement: First identification of CHMP2B mutations in FTD
- statement: CHMP2B localizes to late endosomes, lysosomes, and cytosol
- statement: Mutations cause enlarged endosomes and neuronal dysfunction
- id: PMID:16505166
title: Recycling of ESCRTs by the AAA-ATPase Vps4 is regulated by a conserved
VSL region in Vta1
findings:
- statement: ESCRT-III subunits are recycled by VPS4 for multiple rounds of
MVB formation
- id: PMID:16554368
title: The ESCRT-III subunit hVps24 is required for degradation but not silencing
of the epidermal growth factor receptor
findings:
- statement: ESCRT-III localizes to MVB membranes
- statement: Required for MVB sorting pathway function
- id: PMID:16730941
title: "A systematic analysis of human CHMP protein interactions: additional MIT domain-containing proteins bind to multiple components of the human ESCRT III complex."
findings:
- statement: CHMP2B interacts with CHMP3 and other ESCRT-III subunits
- statement: MIT domain-containing proteins bind to multiple ESCRT-III components
- id: PMID:16807408
title: "ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)."
findings:
- statement: CHMP2B mutations cause ALS phenotypes
- statement: Expands disease spectrum beyond FTD
- id: PMID:17683935
title: ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration.
findings:
- statement: CHMP2B is required for autophagy
- id: PMID:17928862
title: ESCRT-III recognition by VPS4 ATPases
findings:
- statement: Structure of CHMP2B MIT-interacting motif with VPS4B
- statement: CHMP2B binds VPS4A and VPS4B for complex disassembly
- id: PMID:17984323
title: Functional multivesicular bodies are required for autophagic clearance
of protein aggregates associated with neurodegenerative disease
findings:
- statement: ESCRT depletion or CHMP2B mutants inhibit autophagy
- statement: Causes accumulation of ubiquitin/p62-positive aggregates
- statement: CHMP2B mutations disrupt TDP-43 clearance
- statement: Links ESCRT dysfunction to neurodegeneration
- id: PMID:19056867
title: Large-scale proteomics and phosphoproteomics of urinary exosomes
findings:
- statement: CHMP2B detected in urinary exosome proteome
- id: PMID:19234443
title: Membrane scission by the ESCRT-III complex
findings:
- statement: ESCRT-III alone can drive membrane fission
- statement: Three ESCRT-III subunits sufficient for vesicle detachment
- statement: VPS4 required for recycling, not scission
- id: PMID:20588296
title: "Membrane budding and scission by the ESCRT machinery: it's all in the\
\ neck."
findings:
- statement: Review of ESCRT-III mechanism in membrane remodeling
- id: PMID:20616062
title: Human ESCRT-III and VPS4 proteins are required for centrosome and spindle
maintenance
findings:
- statement: ESCRT-III depletion inhibits abscission
- statement: Also affects centrosome and spindle maintenance
- statement: VPS4 localizes to spindle poles and midbodies
- id: PMID:21118109
title: The role of ESCRT proteins in fusion events involving lysosomes, endosomes
and autophagosomes.
findings:
- statement: CHMP2B participates in autophagy and MVB-lysosome fusion
- id: PMID:21975012
title: ESCRT-III subunits Snf7-1 and Snf7-2 differentially regulate transmembrane
cargos in hESC-derived human neurons.
findings:
- statement: CHMP2B interacts with CHMP4B for ESCRT-III assembly
- id: PMID:22046132
title: 'The SARS-coronavirus-host interactome: identification of cyclophilins
as target for pan-coronavirus inhibitors.'
findings:
- statement: CHMP2B interacts with viral Rep proteins
- id: PMID:23051622
title: ESCRT-III CHMP2A and CHMP3 form variable helical polymers in vitro and
act synergistically during HIV-1 budding
findings:
- statement: ESCRT-III forms helical polymers
- statement: CHMP2A and CHMP3 act synergistically in viral budding
- id: PMID:23533145
title: In-depth proteomic analyses of exosomes isolated from expressed prostatic
secretions in urine
findings:
- statement: CHMP2B detected in exosome proteome
- id: PMID:24095276
title: Syntaxin 13, a genetic modifier of mutant CHMP2B in frontotemporal dementia,
is required for autophagosome maturation
findings:
- statement: Syntaxin 13 is a genetic modifier of CHMP2B
- statement: Both are required for autophagosome maturation
- id: PMID:24107264
title: ESCRT requirements for EIAV budding
findings:
- statement: ESCRT-III required for equine lentivirus budding
- id: PMID:24482116
title: ESCRT machinery is required for plasma membrane repair
findings:
- statement: ESCRT performs membrane sealing during plasma membrane repair
- id: PMID:24878737
title: Structure of cellular ESCRT-III spirals and their relationship to HIV budding
findings:
- statement: Cryo-EM structure of ESCRT-III spirals
- statement: Direct visualization at HIV budding sites
- id: PMID:25468996
title: E-cadherin interactome complexity and robustness resolved by quantitative
proteomics
findings:
- statement: CHMP2B detected in E-cadherin interactome
- id: PMID:26040712
title: Spastin and ESCRT-III coordinate mitotic spindle disassembly and nuclear
envelope sealing
findings:
- statement: ESCRT-III recruited to NE during anaphase
- statement: Coordinates with spastin for spindle disassembly
- statement: Localizes to kinetochores and midbody
- id: PMID:26040713
title: ESCRT-III controls nuclear envelope reformation
findings:
- statement: CHMP2A/B encircle forming daughter nuclei during telophase
- statement: ESCRT-III localizes to sites of annular fusion
- statement: Required for NE integrity and sealing
- id: PMID:26496610
title: A human interactome in three quantitative dimensions organized by stoichiometries
and abundances
findings:
- statement: CHMP2B-CHMP4B interaction confirmed
- id: Reactome:R-HSA-3159232
title: Recruitment Of HIV Virion Budding Machinery
findings:
- statement: CHMP2B participates in HIV budding pathway
- id: Reactome:R-HSA-917693
title: ESCRT Disassembly
findings:
- statement: CHMP2B is recycled by VPS4
- id: Reactome:R-HSA-917700
title: MVB Vesicle Formation
findings:
- statement: CHMP2B functions in MVB formation
- id: Reactome:R-HSA-9668389
title: VPS4 binds ESCRT-III assemblies at nuclear envelope (NE) fenestrations
findings:
- statement: CHMP2B participates in NE sealing pathway
- id: Reactome:R-HSA-9668395
title: CHMP7 binds CC2D1B
findings:
- statement: CHMP2B in ESCRT-III NE recruitment pathway
- id: Reactome:R-HSA-9668398
title: CHMP7 binds CHMP4B, which recruits other subunits of the ESCRT-III complex
findings:
- statement: CHMP2B recruited as part of ESCRT-III assembly at NE
- id: Reactome:R-HSA-9668405
title: SPAST (spastin) binds the IST1 subunit of ESCRT-III at the sites of microtubule
attachment to chromatin
findings:
- statement: CHMP2B in pathway with spastin and IST1
- id: Reactome:R-HSA-9668415
title: VPS4 mediates disassembly of ESCRTIII subunits to promote sealing of holes
in the nuclear envelope
findings:
- statement: CHMP2B disassembled by VPS4 during NE sealing
- id: Reactome:R-HSA-9668419
title: SPAST (spastin) mediates the severing of microtubules at chromosome attachment
sites
findings:
- statement: CHMP2B in pathway coordinating spindle disassembly and NE sealing
- id: PMID:21044950
title: Genome-wide YFP fluorescence complementation screen identifies new regulators
for telomere signaling in human cells.
findings:
- statement: CHMP2B interacts with TERF2IP in yeast two-hybrid screen
- id: file:human/CHMP2B/CHMP2B-deep-research-falcon.md
title: Deep research report on CHMP2B
findings: []
proposed_new_terms: []
suggested_questions:
- question: What is the precise stoichiometry of CHMP2B within ESCRT-III polymers?
- question: How does K6 methylation by SMYD2 regulate CHMP2B polymerization dynamics?
- question: Are there tissue-specific differences in CHMP2B function that explain
selective neuronal vulnerability in FTD/ALS?
suggested_experiments:
- description: Structural studies of CHMP2B in the context of full ESCRT-III polymers
at near-atomic resolution
- description: Live-cell imaging of CHMP2B dynamics during nuclear envelope reformation
- description: Proteomics of CHMP2B interactome in neurons versus non-neuronal cells